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Investigating mechanisms of
endogenous, systems-level
coordination in stress adaptation and
homeostasis
Alain R Bonny
Abstract
Cells routinely deploy a spectrum of specialized counter-measures to deal with stress.
However, a near constant feature of response to stress is a down regulation or arrest of the
cell cycle. It has been widely assumed that this cell cycle modulation facilitates a faster
cellular adaptation, a hypothesis that has been posited but still awaits strong support.
Here, we used the S. cerevisiae hyperosmotic shock response as a model system to pursue
the role of cell cycle arrest in stress adaptation. We found that decoupling the stress
response program from the cell cycle led to an adaptive program that was accelerated
compared to the wild type strain. Furthermore, we uncovered that stress-induced cell cycle
vii
arrest restricted the utilization of metabolic resources, whereas unabated cell cycle
progression diverted a surplus into the stress adaptation response. To probe why a wild
type cell would ration its metabolic resources for an ostensibly suboptimal response, we
identified an adaptive tradeoff that makes this rationing of resources advantageous under
repeated stress. Given the universality of cell cycle regulation in stress responses, we
suggest that this study might present a new paradigm in which the coordinated action of
stress responses, cell cycle and metabolism help cells navigate the tradeoffs between rapid
stress adaptation and long-term robustness.
viii
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Chapter 1
Introduction
A paramount task that cells must address how to survive and thrive in a changing
environment. Cells have evolved to maintain physiological processes within a range of
homeostatic environmental conditions (ref); however, when conditions push a cell beyond
the range of its homeostasis, the cell must adapt to stress. Previous work has elucidated
the cognate pathways that are primarily responsible for mitigating the effect of the stress,
demanding cellular resources. The sudden activation of these stress responsive pathways is
at odds with other resource-intensive pathways that are continuously active, such as the
cell cycle. To alleviate this conflict over resources, it’s been observed that the activation of
stress response pathways usually coincides with the arrest of the cell cycle, this allowing
the cell to divert resources. It’s now appreciated that cell cycle arrest during adaptation to
stress adaptation is a fundamental aspect of stress response (ref), but the precise role of
cell cycle arrest in the reallocation of resources remains elusive.
In chapter one of this work, I used the S. cerevisiae hyperosmotic shock response as a
model system to pursue this question, where I found a surprising answer that seems to defy
current hypotheses. In short, I found that decoupling the stress response program from the
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cell cycle machinery led to an adaptive stress response that was substantially accelerated
compared to the wild type strain. I pursued this observation mechanistically to uncover
that stress-induced cell cycle arrest tapered the flux of metabolic resources, whereas
aberrant cell cycle progression diverted a surplus into the stress adaptation program. I
then went further, asking why a wild type cell would ration its metabolic resources,
mediated through cell cycle control, even under acute stress. I uncovered a fitness tradeoff
that makes this rationing of resources beneficial under repeated stress. Given the
universality of cell cycle regulation in stress responses, we argue that this work provides a
mechanism for how cells sacrifice faster adaptation for long-term robustness.
In addition to hypothesis-driven work, in chapter two I demonstrate the ability to build
new tools to enable new lines of questioning. Here, I present a mammalian cloning toolkit
library to enable the rapid assembly of gene circuits. This toolkit leverages the wide
availability of tools, but introduces these disparate tools into a centralized, modular cloning
system that we believe will become an invaluable resource as synthetic biology is used
across multiple disciplines in engineering biology.
2
Chapter 2
Stress-Induced Transient Cell Cycle
Arrest Coordinates Metabolic
Resource Allocation to Balance
Adaptive Tradeoffs
2.1 Abstract
The ability of a cell to mount a robust response to an environmental perturbation is
paramount to its survival. While cells deploy a spectrum of specialized counter-measures to
deal with stress, a near constant feature of these responses is a down regulation or arrest of
the cell cycle. It has been widely assumed that this modulation of the cell cycle is
instrumental in facilitating a faster response towards cellular adaptation. Here, we directly
investigate the role of cell cycle arrest in the hyperosmotic shock response of the model
organism S. cerevisiae by deleting the osmoshock-stabilized cell cycle inhibitor Sic1, thus
3
enabling concurrent stress response activation and cell cycle progression. Contrary to
expectation, we found that removal of stress-induced cell cycle arrest accelerated the
adaptive response to osmotic shock instead of delaying it. Using a combination of time
time-lapse microscopy, genetic perturbations and quantitative mass spectrometry, we
discovered that unabated cell cycle progression during stress enables the liquidation of
internal glycogen stores, which are then shunted into the osmotic shock response to fuel a
faster adaptation. Therefore, osmo-adaptation in wild type cells is delayed because cell
cycle arrest diminishes the ability of the cell to tap its glycogen stores. However,
acceleration of osmo-adaptation in mutant cells that do not arrest comes at the cost of
acute sensitivity to a subsequent osmo-stress. This indicates that despite the ostensible
advantage faster adaptation poses, there is a trade-off between the short-term benefit of
faster adaptation and the vulnerability it poses to subsequent insults. We suggest that cell
cycle arrest acts as a carbon flux valve to regulate the amount of material that is devoted
to osmotic shock, balancing short term adaptation with long-term robustness.
2.2 Introduction
Cells and organisms are constantly challenged in their environment with insults that vary
in origin, magnitude and duration. In order to respond to these insults, cells have evolved a
large battery of adaptive stress responses that allow them to survive and maintain their
homeostasis. Different stress responses show a remarkable diversity in their sensing,
regulation, and logic1–5. However, an almost constant feature of any stress response is the
involvement of cell cycle slow-down or arrest6–10. It is widely assumed that this is because
it is advantageous for a cell not to divide during stressful conditions in order to safeguard
its own fitness and that of its future progeny11,12. Furthermore, by arresting division,
resources and energy can be diverted from the replication and division program to the
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stress response program, allowing it to proceed faster or more efficiently13. Despite the
near universality of these assumptions, the precise contribution of cell cycle arrest to
adaptation remains poorly understood.
In the model organism Saccharomyces cerevisiae, two models for the interaction
between cell cycle arrest and stress pathways have been proposed. In the first model, the
cell cycle is deemed to be a passive recipient of upstream signals from the stress-sensing
pathway, with several studies showing that the onset of a stress condition coincides with a
downregulation of the cell cycle11,14. In the second model, the cell cycle is considered to be
an important factor in the stress response, acting as the arbiter of the stress-handling
capacity of the cell. To support this model, studies have demonstrated that the rate of cell
cycle progression (i.e. growth rate) is a large contributor to survival under a variety of
stresses, with slower growing cells being more fit in nutrient poor media and heat shock as
well as other environmental insults15,16. Evidently, these models are not incompatible and
strong data exist to support both. For example, growth rate is undeniably a contributing
factor in mounting a robust stress response, and its effect has been demonstrated from
bacteria to higher eukaryotes17. At the same time, yeast strains absent stress-sensing
effectors display poor survival in the face of cognate insults irrespective of growth rate,
further supporting the importance of frontline stress sentinels2,18–20. It is likely that a more
applicable model is one in which a stress pathway can modulate cell cycle progression and
changes in the cell cycle can feedback to actively modulate the stress response.
To explore this paradigm, we used the hyperosmotic glycerol (HOG) response as a
convenient framework. The HOG program is a canonical stress response activated by the
presence of excess osmolytes in the extracellular environment. The increase in osmotic
pressure difference between the inside and outside of the cell drives water out, causing the
cellular volume to decrease. At the onset of a step input of hyperosmotic shock, the central
HOG mediator, Hog1, rapidly translocates from the cytoplasm to the nucleus where it
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interacts with a variety of targets to initiate the production and accumulation of glycerol21.
The accumulation of glycerol in the cytoplasm re-establishes the osmotic pressure gradient
to its basal level, and once volume has been corrected, Hog1 exits the nucleus22.
Importantly, in addition to the initiation of glycerol synthesis, Hog1 stabilizes the
stoichiometric inhibitor of b-type cyclins 5 and 6, Sic1, to transiently arrest the cell in the
G1 phase of the cell cycle11. Volume restoration and exit of Hog1 from the nucleus also
coincides with resumption of cell cycle progression23. The adaptive translocation pattern of
Hog1 has been the subject of many studies for its robust, reproducible and stereotyped
pattern, which acts as a real-time reporter of hyperosmotic adaptation24,25.
Using HOG as a model system, we investigated the role of transient cell cycle
arrest in the adaptive response to hyperosmotic shock. Our approach was to decouple the
HOG response program from the canonical cell cycle machinery such that both processes
proceed simultaneously during osmotic shock. By following Hog1 translocation as a
reporter of HOG adaptation, we were able to quantify deviations from Hog1’s stereotyped
translocation pattern as an indication of an altered stress response. Surprisingly, we found
that unabated cell cycle progression during osmoshock accelerated osmo-adaptation as
measured by Hog1 translocation. Remarkably, other canonical markers of adaptation such
as glycerol production and volume recovery also proceeded faster. These data indicated
that cell cycle arrest impedes, rather than facilitates, adaptation to stress. To pinpoint the
mechanistic roots of this phenotype, we used mass spectrometry 13C isotope tracing to
probe the differences in metabolic flux between wild type and cell cycle arrest-disabled
cells. We discovered that progression in the cell cycle during osmostress initiated
catabolism of internal glycogen that was mediated by the enzyme Gph1. Breakdown of
glycogen fueled faster glycerol synthesis in the mutant cells, giving them the ability to
restore turgor pressure faster than wild type. Therefore, cell cycle seems to be the guardian
of a metabolic valve that remains closed when cell cycle is arrested. To investigate what
vulnerabilities arise from opening of this valve, and rationalize why the wild type cells still
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implement cell cycle arrest despite the delay it imposes on stress adaptation, we subjected
cells to repeated osmostress pulses. Under these conditions, wild type cells maintain
substantial population viability while cells lacking arrest display worse survival, which
keeps diminishing upon repeated stress pulses. Therefore, while adaptation to an osmotic
stress proceeds faster when there is no cell cycle arrest, this phenotype leaves the cell
particularly susceptible to subsequent osmoshocks. We believe that these data dispute the
notion that cell cycle arrest or slow-down simply underlies rapid recovery from one instance
of stress, instead suggesting that these relationships are multifactorial with complexities
that we are yet to understand. Our findings also pinpoint an example where connection
between three important cellular networks - a stress pathway, cell cycle regulation, and
metabolic control - seem to collaborate in order to strike a balance between mounting a
rapid adaptive response to acute threats and ensuring viability in the face of future insults.
2.3 Removal of Hog1-mediated cell cycle arrest
accelerates adaptation to hyperosmotic shock
To assess the role of cell cycle arrest in adaptation to osmotic shock, we removed the
ability of Hog1 to initiate G1-phase cell cycle arrest by generating a sic1∆ knockout strain
(Figure 2.1A). In this strain, we tagged Hog1 with mVenus at its endogenous locus to allow
visualization of its nuclear translocation by microscopy. We also incorporated the same
Hog1-mVenus construct in a wild type (WT) strain to allow for the comparison of its Hog1
dynamics with those of the sic1∆ mutant. For precise temporal control in applying a step
input of osmotic shock, we used a commercially available microfluidic platform that
allowed us to quickly induce osmoshock and monitor Hog1 dynamics in the sic1∆ and WT
strains by time lapse microscopy. We chose the osmolyte sorbitol as the input to induce
hyper-osmotic stress because it is an inert sugar in the presence of glucose26.
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Using this experimental setup, we subjected WT and sic1∆ mutant cells to a step
input of 1.2 M sorbitol osmoshock and monitored Hog1 nuclear translocation dynamics.
Following the sorbitol input, Hog1 rapidly translocated to the nucleus in both strains with
similar nuclear influx dynamics (Figure 2.1B). The degree of maximum nuclear enrichment
was virtually indistinguishable in both strains, suggesting that the mutant maintains the
ability to sense and respond to acute osmotic shock. In the WT strain, Hog1 exited the
nucleus and its cytoplasmic levels adapted to the pre-stimulus values within 45 minutes on
average, consistent with previous reports25. Surprisingly, however, the return of Hog1 to
the cytoplasm was much faster in the sic1∆ cells, occurring on average within 33 minutes
(Figure 2.1C). This constitutes a significant 30% speed-up compared to WT (Figure 2.1C,
right). This acceleration of Hog1 adaptation in non-arresting cells was not a
sorbitol-specific effect, since experiments carried out with NaCl also showed the same
phenotype (Supplemental Figure 2.5A, 2.5B). Additionally, despite the protein Sic1 being
typically described as G1-specific regulator, we observe this phenotype averaged over the
entire asynchronous population, likely underestimating the effect of its deletion.
Furthermore, prior work has shown strongly correlated transcriptional response between
G1- and G2-arrested cells suggesting that the phenotype we observe is the direct result of
HOG activated during concomitant cell cycle progression13.
The faster Hog1 response in sic1∆ cells can be the result of a breakdown of
coordination between the regulatory osmotic response and turgor pressure of the cell. If
this were the case, then Hog1 would recover its cytoplasmic localization without full
recovery in other physiological parameters such as cellular volume and glycerol
accumulation necessary for this recovery. On the other hand, if the fast Hog1 adaptation
were the result of an acceleration within an intact recovery program, then the profile of
volume recovery and glycerol accumulation should also be accelerated. We therefore
investigated these critical phenotypes to see if the integrity of the adaptive program is
maintained despite accelerated Hog1 dynamics in the sic1∆ strain.
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First, we measured internal glycerol content using a commercial colorimetric assay
following a 1.2M sorbitol input over 60 minutes in both the WT and sic1∆ strains (Figure
2.1D). Using this assay, we determined that both WT and mutant cells upregulated their
glycerol production by 5-fold at the end of the 60 minutes. However, while the WT cells did
not begin to dramatically upregulate glycerol production until 30 minutes after the onset of
stress, sic1∆ began increasing glycerol synthesis only 15 minutes after stress (Figure 2.1D,
inset). In agreement with this finding, quantification of cellular surface area as a surrogate
for volume also showed a faster recovery for the mutant relative to the WT (Figure 2.1E,
top). While this volume recovery phenotype was reproducible, its extent was slightly lower
than the Hog1 and glycerol phenotype, showing a 15% difference between WT and mutant
(Figure 2.1E, right). This could be due to the difficulty in cell tracking and quantification
of surface area, or to a strict upper limit on the expansion properties on the cell wall27.
Taken together, the three phenotypes strongly support the hypothesis that the mutant has
the same coordinated osmotic stress response as the WT type, but with faster dynamics
that ensue from the inability of these cells to arrest their cell cycle during osmotic shock.
2.4 Glycerol production is accelerated using internal
sources in mutant that lacks cell cycle arrest
Because Hog1 translocation, glycerol production and volume all correlate with faster
recovery dynamics in the mutant strain, we next sought to investigate if another cellular
process was fueling the accelerated production of glycerol, the catalyst for osmotic shock
recovery. We hypothesized that a surplus of carbon material from central glycolysis could
be shunted into glycerol production, thus resulting in heightened glycerol synthesis. One
scenario for this to happen is one in which the deletion of Sic1 augments the ability of cells
to import extracellular glucose, resulting in a greater amount of carbon material entering
9
glycolysis to be directed towards glycerol production. To test this hypothesis we performed
a mass spectrometry 13C isotope tracing experiment to compare the glucose uptake rate
between the mutant and WT strains. In this experiment, cells were grown in 12C glucose
media. At time zero, an aliquot of cells was transferred onto filter paper over a vacuum
manifold and continuously perfused with fully-labeled 13C glucose media with and without
1.2 M sorbitol for various durations before quenching the sample (Figure 2.2A,
Supplemental Figure 2.6A). A pilot experiment (not shown) suggested that turnover rates
of glycolytic intermediates occur on the order of seconds, with intermediates reaching
steady-state after 1 minute. Therefore, we chose to quench samples at 10, 20, 30, 45 and 60
seconds in order to capture the rate at which the internally 12C-enriched glycolysis
intermediates are degraded and newly synthesized metabolites incorporate the perfused
13C. We measured 13C incorporation in a number of metabolites representative of central
glycolysis and the glycerol branch. Consistent with a fast turn-over of these metabolites,
we observed a rapid decay of 12C enrichment among the glycolysis intermediates within
seconds. In the examples of Glucose-6-Phosphate (G6P) and fructose bisphosphate (FBP),
the sic1∆ strain incorporated 13C with a slower rate than the WT in the presence and
absence of osmotic shock (Figure 2.2B, Supplemental Figure 2.6B). Using the decay rate of
12C enrichment as a surrogate for glucose uptake, we derived glucose import rates of 0.117
s-1 and 0.04 s-1 for WT and sic1∆, respectively, during osmotic shock for G6P. Similarly,
FBP incorporated 13C at rates of 0.12 s-1 and 0.064 s-1 for WT and sic1∆, respectively.
The approximately 2-to-3-fold slower glucose uptake rate in the sic1∆ mutant was
consistent for all glycolysis intermediates we targeted from upper glycolysis in
glucose-6-phosphate (G6P) to phosphoenolpyruvate (PEP) in lower glycolysis
(Supplemental Figure 2.6B, 2.6C). Therefore, it is clear that the faster recovery of the
sic1∆ mutant cannot be ascribed to uptake of external glucose, since the mutant is visibly
slower at glucose uptake. Slower glucose uptake often has the implication of a reduced
doubling rate, which has been suggested to confer an advantage during stress
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adaptation16,28. We measured the growth rate of the sic1∆ mutant and observed that it
has a doubling time of 3.4 hours compared to 2.1 hours of the WT in defined media
(Supplemental Figure 2.7A). To assess whether slower growth could be correlated to the
accelerated osmoshock adaptation, we compared the growth rate of all strains used in this
study (see subsequent sections for different strains, including those with different deletions
in metabolic genes) against their respective adaptation time (Supplemental Figure 2.7B).
We found a weak correlation (R =0.34, P =0.51) between the growth rate of the strains
tested and their adaptation time to osmotic stress, suggesting that while growth may
contribute to the accelerated phenotype, it is unlikely to be the only factor. The difference
in glucose uptake rates between WT and sic1∆ suggest that the mutant is not importing
more extracellular carbon material into glycolysis. To further investigate the source of its
accelerated glycerol production, we reasoned that if the excess carbon material was not
from extracellular sources, then it was conceivable that the glycerol synthesis in sic1∆
could be assisted by diverted intracellular carbon stores. To investigate this possibility, we
again turned to 13C mass spectrometry isotope tracing to test whether, and to what extent,
intracellular carbon was used for glycerol production in both strains. In order to selectively
enrich internal stores with a unique carbon isotope, we grew the cells on 12C glucose, and 5
minutes before time zero, resuspended the cells in fully-labeled 13C glucose. We then
continued this treatment with and without osmoshock (1.2M sorbitol) for the remainder of
the experiment, collecting samples until 30 minutes after osmoshock (Figure 2.2C). Based
on the rapid turn-over of glycolytic intermediates (Supplemental Figure 2.6B, 2.6C), we
hypothesized that within 5 minutes all glycolysis intermediates will be 13C enriched, but
macromolecules such as storage carbohydrates would remain enriched in 12C due to their
slower turn-over29. Given that the cell is only provided 13C carbon at the onset of osmotic
shock, and glycolysis intermediates likely enriched 13C in the 5 minutes before stress, any
detection of 12C after HOG activation would implicate the liquidation of an internal
macromolecule. By monitoring the panel of targeted metabolites in glycolysis and glycerol
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precursors, we detected 12C enrichment along central glycolysis, suggesting that both
strains liquidated internal stores during osmoshock. The dynamic pattern of 12C
enrichment of metabolites for the WT cells showed pattern of low and unchanged level
(FBP and PEP) or a level that declined as a function of time (G6P and DHAP) (Figure
2.2D, Supplemental Figure 2.8B). The temporal enrichment dynamics of the sic1∆ mutant,
however, was markedly different showing a transient peak of 12C enrichment followed by a
decrease for all metabolites (Figure 2.2D, Supplemental Figure 2.8B). In the first step of
glycolysis, the metabolite G6P started with a low 12C enrichment, which increased and
peaked between 1 and 5 minutes and subsequently decreased. The same pattern was
present for glycolysis intermediates FBP and PEP. More importantly, this same transient
12C signature was present in the glycerol production branch represented by
dihydroxyacetone phosphate (DHAP). This transient 12C enrichment pattern in the sic1∆
mutant suggests that 12C in glycolysis intermediates is temporarily replaced by 12C from
carbohydrate stores in a flux that traverses the metabolic route to glycerol production.
However, after this wave, external 12C is incorporated again in metabolites, underlying the
subsequent decline in 12C enrichment. It is worth noting that in the absence of stress, the
WT had a higher basal 12C enrichment likely due to a higher basal turnover rate of
macromolecules, consistent with its faster growth rate than the sic1∆ strain29. Only
during the onset of stress did the sic1∆ mutant have a brief, higher 12C enrichment with
the aforementioned peak throughout (Figure 2.2C, Supplemental Figure 2.8B).
Collectively, these data strongly suggest that, unlike the WT, the sic1∆ briefly shunts
internal carbon stores as extra flux into glycerol production at the beginning of osmotic
shock. Interestingly, the immediate precursor to glycerol, glycerol-3-phosphate (Gl3P), had
an order of magnitude greater proportion of 12C compared to the other metabolites tested
(Figure 2.2D). The increase in 12C could be attributed to back-flux from existing
12C-enriched glycerol by way of a futile cycle to degrade excess ATP during severe stress30.
Despite the discrepancy between Gl3P and DHAP, the sic1∆ strain was still enriched with
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a greater amount of 12C than the WT, likely reflecting the convergence of the
aforementioned futile cycle and excess internal carbon liquidation.
2.5 Internal glycogen is liquidated using the Gph1
enzyme and shunted into glycerol production in
mutant that lacks cell cycle arrest
Previous studies have established links between cell cycle progression and glycolysis as
processes that are integral to cellular physiology31? ,32. These links are mediated
mechanistically through biochemical interactions between cell cycle regulators such as
CDK1 and storage catabolism enzymes for trehalose and glycogen (Nth1 and Gph1,
respectively)33,34. Given these data, we hypothesized that during osmotic shock, the sic1∆
mutant could activate storage catabolism enzymes through unabated cell cycle progression,
resulting in a burst of glycolytic flux that was then shunted into excess glycerol production
(Figure 2.3A). Further, we predicted that by coupling either a Nth1 or Gph1 knockout
with sic1∆, we could rescue the mutant to the WT phenotype, for example as measured by
Hog1 localization dynamics. Cellular trehalose levels have been widely established as
mediators of stress recovery35. However, surprisingly, in a sic1∆nth1∆ mutant, Hog1
nuclear levels still adapted significantly faster than in WT following osmotic stress
(Supplemental Figure 2.3A, 2.9B), suggesting that trehalose is not the main liquidated
internal carbon source. However, when we coupled the sic1∆ deletion with a knockout of
Gph1 (sic1∆gph1∆ mutant), Hog1 adapted nearly 30% slower, closely resembling WT
recovery time (Figure 2.3B, 2.3C). When we combined these genetic perturbations in a
sic1∆nth1∆gph1∆ strain, Hog1 again adapted in time comparable to WT, supporting the
notion that the Gph1-mediated breakdown of glycogen is the main driver of the accelerated
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sic1∆ phenotype (Supplemental Figure 2.3C). To ensure that the gph1∆ rescue is specific
to mitigate the effect of sic1∆, and not a broad glycolytic flux perturbation irrespective of
genetic background, we predicted that Gph1-mediated glycogen breakdown would not affect
an otherwise WT Hog1 response, because glycogen catabolism is halted due to normal cell
cycle arrest. Indeed, in support that gph1∆ is a specific rescue to sic1∆ phenotype, Hog1
adaptation time following osmostress in gph1∆ cells is nearly indistinguishable from the
WT response (Supplemental Fig 2.9B, 2.9C). Consistent with the rescue in Hog1 dynamics,
we observed that the deletion of Gph1 counter-acted the sic1∆ effect and reduced the
glycerol accumulation in a manner commensurate to the WT rate (Figure 2.3D).
2.6 Accelerated recovery due to glycogen storage
liquidation during osmotic shock prioritizes faster
adaptation over robustness to repeated insults
Bypassing cell cycle arrest during osmotic shock results in accelerated recovery due to cell
cycle-mediated carbon flux shunted into glycerol production. This suggests that the sic1∆
mutant might have an advantage upon one instance of osmotic stress. Conceivably,
multiple instances of osmotic shock can amplify the advantage that sic1∆ cells have over
WT cells. Alternatively, the faster recovery advantage of sic1∆ cells might come at the
cost of other vulnerabilities that are only revealed dynamically36. To test the endurance of
sic1∆ mutant upon a series of osmotic shocks, we subjected cells to the same 90 minute
step input of 1.2 M sorbitol as before, but followed by three 45 minute shocks separated by
5 minutes (Figure 2.4A). At the end of each step input, we calculated the relative
adaptation time using Hog1 nuclear residence as a metric and also assessed the viability of
cells. After the first osmotic shock, both strains adapt as previously shown, with the sic1∆
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mutant recovering faster than its WT counterpart (Figure 2.4B). Following the first step
input, adaptation to subsequent osmostress inputs proceeded faster (around 50% faster in
this case) in both WT and mutant strains due to accumulation of glycerol from the
previous cycle and consistent with previous reports36 (Figure 2.4C). However, in the
subsequent pulses, many sic1∆ mutant cells started exhibiting morphological differences
from their WT counterparts. These cells displayed a deflated phenotype with visible
material accumulated in the nearby vicinity, suggesting the cell lysed and released
intracellular debris. This morphology is consistent with a breakdown of cell wall integrity,
which is a common mechanism of death in serial osmotic shock perturbations27.
Algorithmic quantification of this phenotype revealed a marked increase in cells that have a
breakdown in their cell wall integrity for each subsequent pulse. By the end of the fourth
step input of osmotic shock, 25% of sic1∆ cells displayed a cell wall-compromised
morphology, while only 5% of WT cells displayed a similar phenotype (Figure 2.4D, 2.4E).
Interestingly, the sic1∆gph1∆ genetic background shares the same acute vulnerability as
sic1∆ to repeated osmotic pulses despite its adaptation that resembles that of the WT.
However, the triple mutant sic1∆nth1∆gph1∆ is able to survive the sequential osmoshocks
in a manner that is more similar to the WT (Supplemental Figure 2.10D). This difference
in vulnerability suggests unique roles for the breakdown of trehalose and glycogen that
warrant further investigation. Nonetheless, it is clear that while the accelerated adaptation
ostensibly provides an advantage in the face of a single step input of osmotic shock, the
sic1∆ mutant is severely ill-suited for repeated insults.
2.7 Discussion
Cell cycle dynamics have a fundamental presence in many adaptations to stress, but a
mechanistic understanding of its role has long been outstanding. Here we attempted to
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understand some aspects of the role of cell cycle arrest in the context of the well-studied
HOG pathway and associated osmotic stress. Our main experiment was to decouple the
HOG stress program from the cell cycle machinery and monitor the nuclear localization
dynamics of HOG master effector (Hog1). This experiment revealed that the normally
stereotyped behavior of Hog1 accelerated in cells where cell cycle cannot arrest upon
osmoshock. From there, we confirmed that the HOG program was still competent by
looking to other canonical hallmarks of osmoshock recovery - internal glycerol content and
cellular volume. Following the hypothesis that an upstream process was dictating the faster
dynamics, we utilized quantitative mass spectrometry to implicate faster internal glycogen
liquidation by the mutant as a route by which glycerol synthesis increases and mediates
faster adaptation to the stress. In strong agreement with this insight, deletion of glycogen
catabolism enzyme Gph1 rescues the sic1∆ Hog1 translocation and glycerol accumulation
phenotypes. Puzzled by the observation that the WT is not optimal with respect to the
speed of its recovery, we hypothesized that the mutant might have vulnerabilities that the
WT can circumvent. Following this reasoning, we identified a critical failure mode of the
mutant by subjecting it to multiple step inputs of osmotic shock. The mutant adapts faster
and maintains viability after the first osmotic shock, but trades its faster initial adaptation
for susceptibility to subsequent osmoshocks, as nearly a quarter of the population is dead
by the last insult. Meanwhile, the WT adapts slower after the initial osmotic shock, but
maintains nearly 95% viability throughout the experiment, thus highlighting the dichotomy
between apparent short-term gain versus long-term resilience against a dynamic
environment. We believe that the main contribution of this work is two-fold. First, our
investigations provide a higher resolution dissection of the interconnection between three
crucial cellular pathways: the cell cycle, the HOG stress response, and carbon metabolism.
Contrary to expectation, this connection is not perfectly tuned to maximize the speed of
adaptation to stress. In fact, the connection of the HOG pathway to the cell cycle
diminishes the ability of the cell to recover rapidly following osmostress, and ablation of
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this connection allows the cell to recover a substantial 30% faster. The cell cycle seems to
be the gatekeeper of a metabolic valve that can augment carbon flow into glycerol from
internal resources, but this valve remains shut in WT type cells. Opening of this valve in
mutant (sic1∆) cells seems to mediate their faster recovery, as evidenced by a gph1∆
mutant in which deletion of the enzyme presiding over the internal flux from glycogen to
glycerol abolishes the fast osmostress recovery. Therefore, our data provide additional
mechanistic details to an intricate interplay of pathways that together set the cellular
recovery tempo. The second contribution of this work is to formulate an instance in which
cells seem to navigate a delicate functional balance, sacrificing the brief advantage of faster
recovery from an insult for robustness to future environmental changes (Figure 2.4F). The
hypothesis that they evolved to do so prompts us to revise our view of how to interpret the
measured dynamics of stress responses and our assumptions about how cells mobilize their
resources to combat stress. It is clear that at least in the example of osmostress, S.
cerevisiae cells do not maximally mobilize their carbon, and hence sacrifice substantial
speed in their recovery. It is also evident that the cell cycle serves as an arbiter and
enforcer of this suboptimal performance. Since the mutant that circumvents the speed
limitation shows tremendous vulnerability to repeated stress, one is compelled to at least
hypothesize that this cell cycle control has evolved to alleviate such vulnerability in an
environment where repeated or oscillating stress might be more probable. What could be
the nature of the vulnerability that the cell cycle is trying to arbitrate? Prior work
demonstrated complementary roles between the HOG and cell wall integrity (CWI)
pathways, where HOG is activated during the initial shrinkage of the cell, and the CWI is
activated during the subsequent volume expansion and growth37. It is plausible to suggest
that the redirected carbon flux of the sic1 mutant diverts resources away from cell wall
remodeling, potentially explaining why sic1∆ is selectively vulnerable to a series of osmotic
shocks. Evidently, more studies would be necessary to substantiate this hypothesis, but it
is tempting to speculate further on the complex allocation of resources between these core
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cellular processes. The work presented here reframes cell cycle arrest in a mechanistic light
as being a mediator of a slower adaptation response to hyperosmotic shock. In future
investigations, it would be interesting to use a similar approach with conditional or
inducible mutants to test for the role of cell cycle arrest in other stresses, potentially
discovering similar metabolic flux control mechanisms or roles more tailored to specific
stresses. Alternatively, expanding the scope of this question to higher eukaryotes could
further illuminate the complex relationship between cell cycle, metabolism and stress
response, which has been implicated in several pathologies38. More broadly, it is clear that
as we begin to explore how multiple pathways collaborate to allow a cell to navigate its
complex environment, we need to revisit statements about functional allocations and
re-explore plausible but exceedingly simple assignment of roles and assumptions of
unifunctional optimality of any one pathway. We hope that the data presented in this work
form a basis for such investigation, initiated by our more nuanced exploration of the
ubiquitous role that cell cycle arrest plays in stress adaptation.
2.8 Materials and Methods
Strain Construction
The base S. cerevisiae strain used in this study is w303. Hog1-mVenus at the endogenous
locus was generated by ordering oligos of 40 bp homology 5’ upstream of the stop codon,
PCR amplifying the mVenus-HIS3 cassette, and transforming as previously described40.
To knockout genes, 80 bp of homology 5’ to the start codon and 3’ of the stop codon was
used to PCR amplify a selection marker cassette and transformed as described above. PCR
products using oligos in the 5’UTR and internal to the selection cassette were used to
verify knockouts and insertions.
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Growth Conditions
Single colonies were picked and inoculated from auxotrophic SD (6.7 g/L Bacto-yeast
nitrogen base without amino acids, 2 g/L complete amino acid mix, and 20 g/L dextrose)
agar plates. SDC liquid media used throughout the study consisted of 6.7 g/L Bacto-yeast
nitrogen base, 2 g/L complete amino acid mix, and 20 g/L dextrose. Thermocycler
protocols The GG protocol is primarily used for assembly reactions. The reaction
temperature is initially held at 45°C for 2 min to digest the plasmids followed by 20°C for 4
min to anneal constituent parts together. After repeating these first two steps 24 times, the
temperature is increased to 60°C for 10 min to digest remaining recognition sites and
inactivate the ligase. Then the temperature is held at 80°C for 10 min to inactivate the
enzyme. Lastly, the reaction is held at 12°C indefinitely. The “GG End-On” protocol is
used when BsaI or BsmBI sites need to be retained in the final product. The temperature
is initially held at 45°C for 2 min to digest the plasmid followed by 20°C for 5 min to
anneal and ligate the resulting plasmid. These steps are cycled 24 times and then held at
16°C indefinitely.
Microscopy
Time-lapse microscopy was collected on a Nikon Ti inverted scope 40x air objective, with
Sutter XL lamp illumination and a Hamamatsu Flash 4.0 camera. YFP (515 ex/528 em)
channel was collected using a Chroma CFP/YFP filter set with an exposure time of 300
ms. Automated image acquisition was controlled by Nikon NIS Elements proprietary
software. The CellAsics Onix2 Microfludic platform was used to control the changing of
media. Pressure of the media perfusion was held constant at 10.8 psi in a microfluidic plate
designed to trap haploid yeast (Millipore). To ensure that the yeast cells adapted to
conditions within the microfluidic chamber, cells were perfused with normal SDC media for
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90 minutes prior to the osmotic shock in all experiments.
Image Processing
The nucleus of each cell was defined as the mean pixel intensity of the brightest 5% of
pixels over the segmented cell in the YFP channel. The remainder of the cell outside the
brightest 5% was defined as the cytoplasm. Cell tracking and quantification of
nuclear/cytoplasmic enrichment was done using automated yeast cell tracking software
implemented in Matlab41. Nuclear enrichment is plotted as the population average nuclear
to cytoplasmic ratio divided by the average three time points before the onset of osmotic
shock minus one, as previously described23. Cellular volume was calculated from
segmentation of an out of focus brightfield image using the Nucleaizer web interface
(www.nucleaizer.com). The surface area of each cell in pixels was then converted into an
approximate volume as described previously23. This volume was normalized by the three
time points before the onset of osmotic shock.
Mass Spectrometry
Samples were grown overnight to saturation and diluted in SDC media. Cultures were
grown to mid-log and 1 mL was transferred to a 0.45 µm PVDF membrane filter paper
(Millipore), fixed atop a vacuum manifold. Cells were continuously perfused with either
normal SDC media or 1.2 M sorbitol in SDC media for the indicated durations (Figure
2A). At the end of the perfusion period, the filter paper containing cells was immediately
transferred to a 2 mL quenching solution of 40:40:20 Methanol:Acetonitrile:H2O chilled to
-20 °C. After 2 hours incubation at -20 °C, quenching solution plus cells was transferred to
a conical tube and dried for approximately 7 hours in vacuo and resuspended in 45 µL
H2O. In the experiment described in Figure 2C, five minutes prior to time zero 50 mL
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culture were transferred to a conical tube, spun down at 2000 RPM for 2 minutes and
resuspended in 25 mL fully labeled 13C glucose SDC. After time zero, at the indicated
time points, 1 mL of culture was transferred to the same filter paper vacuum manifold
described above, and after media washed through the sample was quenched as described
above. Collected compounds were analyzed using an LC-MS/MS mass spectrometer
system consisting of a 1290 Infinity LC (Agilent Technologies) coupled to a 5500 QTRAP
triple quadrupole mass spectrometer (AB Sciex) in negative mode and with multiple
reaction monitoring (MRM) scan type. Five µL of metabolite extracts were injected on an
Agilent PoroShell 120 HILIC-Z column (150 x 2.1 mm, 2.7 µm; Agilent, Santa Clara, CA)
using a mobile phase A (water, 10 mM ammonium acetate, 5 µM medronic acid, pH 9) and
mobile phase B (90% acetonitrile, 10% water, 10 mM ammonium acetate, 5 µM medronic
acid, pH 9) at a constant flow rate of 250 µl/min; Initial conditions: 10% A, 2 min: 10% A,
12 min: 40% A, 15 min: 40% A, 16 min: 10% A, 24 min: 10% A. The MRM settings were
adapted from Yuan et al39. The raw data were processed and analyzed using custom
software in Matlab (Mathworks).
Intracellular glycerol assay
Each strain was inoculated into SDC media, grown overnight at 30 °C, split and diluted
into six 600 uL 0.1 OD600 cultures in a 96 well 2 mL plate. Once the cells were in log
phase growth, 600 uL of 2.4 M sorbitol was added to one well at time points of 60 minutes,
30 minutes, 15 minutes, 10 minutes, 5 minutes and 0 minutes. After time zero, 200 µL of
each culture was transferred to a separate Corning 3904 96-well assay plate plate for an
OD600 reading, and the remaining 1 mL immediately spun down for 2 minutes at 2000
RPM. Cells were washed in 400 µL H2O, and spun down again for 2 minutes at 2000 RPM.
The culture was then resuspended in 150 µL H2O, and left to incubate for 15 minutes at 95
°C. Following incubation at 95 °C, cells were vortexed for 2 minutes and promptly spun
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down for 10 minutes at 4000 RPM. After the pelleting of cell debris, 100 µL of supernatant
was carefully removed and transferred to a separate plate and kept at 4 °C. Colorimetric
glycerol assays were acquired using a commercial kit (Sigma) where the provided assay
powder was resuspended in 40 mL of distilled H2O. For each sample, 5 µL of supernatant
was added to 400 µL of glycerol free reagent solution, and left to incubate at room
temperature for 15 minutes hidden from light. After 15 minutes, 200 µL of the glycerol free
reagent solution-sample mixture was transferred to a separate plate and the OD540 was
acquired for each sample on a Tecan Spark 10M plate reader. To account for differences in
cell density across samples, the 540 nm readings were normalized by their OD 600 nm
reading values.
Growth Assay
Each strain was inoculated into SDC media overnight, reached saturation and diluted the
following morning to an OD600 of 0.1. After dilution, 200 µL of culture was transferred to
a Corning 3904 96-well assay plate and grown at 30 °C while shaking. Optical density
readings were collected at 600 nm every 20 minutes until saturation on a Tecan Spark 10M
plate reader.
Cell Viability
At the end of each 45 minute step input of osmotic shock, each cell was manually assessed
for cell cycle re-entry and return to basal morphology. Cells that either did not show
continued cell cycle progression, or displayed a visible change in refractive index reflective
of a change in morphology were labeled with altered morphology.
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2.11 Figures
Figure 2.1: Removing cell cycle arrest by deletion of Sic1 accelerates the HOG adaptation
program during osmotic shock.
a. A simplified schematic of the HOG pathway showing its coupling to cell cycle
arrest and glycerol production. In a cell cycle mutant strain sic1∆, we asked whether the
removal of stress-induced cell cycle arrest affects the adaptive response. b. Representative
time lapse images of endogenously-tagged Hog1-mVenus following step input of 1.2 M
sorbitol osmotic shock to WT (top) and sic1∆ (bottom) cells. Quantification of all cells
presented in Panel C. c.Top: Cartoon depicting the translocation dynamics and
quantification of adaptation time. Bottom: Quantification of the WT (blue) and sic1∆
(orange) Hog1-mVenus nuclear enrichment in the experiment described in Panel B. Shaded
regions represent the standard error of the mean (SEM) of n=3 biological replicates. Right:
Quantification of Hog1 adaptation for WT (blue) and sic1∆ (orange). Values are
normalized to the average of WT. Error bars represent the SEM of n=3 biological
replicates. *P-value¡0.05; two-sided Student’s t-test. d. Top: Cartoon schematic depicting
the intracellular accumulation of glycerol. Bottom: Quantification of internal glycerol as a
function of time for WT (blue) and sic1∆ (orange) to a step input of 1.2 M sorbitol
osmotic shock. Measurements are taken using a colorimetric assay. Error bars represent
the standard deviation for n=3 biological replicates. Inset: the change in glycerol,
calculated as the difference between two time points for data in Panel D, is plotted as a
function of time.e. Top: Cartoon schematic depicting volume recovery and quantification
of its adaptation time. Bottom: Change in volume of the WT (blue) and sic1∆ (orange)
strains in response to a step input of 1.2 M sorbitol osmotic shock. Shaded regions
represent the SEM of n=4 biological replicates. Right: Quantification of volume adaptation
time of WT (blue) and sic1∆ (orange) volume. Values are normalized to the average of
WT. Error bars represent the SEM of n=4 biological replicates.
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Figure 2.2: An internal carbon store is shunted towards excess glycerol production during
osmotic shock in the sic1∆ mutant.
a. Cartoon schematic of the experiment to measure extracellular glucose uptake
rates. Cells were inoculated overnight, diluted and outgrown in 12C glucose. At time zero a
1 mL sample of cells was transferred to filter paper above a vacuum manifold and
continuously perfused with fully-labeled 13C glucose media. A 1.2 M sorbitol input was
also administered at time 0. Samples were taken at 10 s, 20 s, 30 s, 45 s, and 60 s and
transferred to quenching solution. b12C enrichment over time of central glycolysis
metabolite Glucose-6-Phosphate (G6P) (Left) and fructose bisphosphate (FBP) (Right).
Traces shown are WT (blue) and sic1∆ (orange) strains for experiment described in Panel
A. Error bars represent the standard deviation of n=2 technical replicates. c Cartoon
schematic of experiment to test internal carbon enrichment of targeted metabolites. Cells
were inoculated overnight, diluted and outgrown in 12C glucose. Five minutes prior to time
zero, cells were resuspended in fully-labeled 13C glucose. At time zero the culture was
diluted 1:1 with 2.4 M sorbitol in fully-labeled in 13C glucose. At the indicated time points,
1 mL of culture was placed on filter paper above a vacuum manifold for the media to wash
through, transferred to quenching solution and then measured. d12C enrichment over time
for a panel of select metabolites in glycolysis and glycerol production. Traces shown are the
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WT (blue) and sic1∆ (orange) strains for experiment described in Panel C. Error bars
represent the standard deviation of n=2 technical replicates.
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Figure 2.3: Glycogen catabolism enzyme Gph1 mediates glycerol synthesis to fuel accelera-
tion phenotype in sic1∆ mutant.
a. Schematic depicting the hypothesis that liquidation of glycogen by activation
of Gph1 accelerates the Hog1-mediated glycerol production. b Left: Traces of Hog1 nuclear
enrichment over time following 1.2 M sorbitol osmotic shock in the WT (blue), sic1∆
(orange), sic1∆gph1∆ (purple) cells. Shaded regions represent the SEM of n=3 biological
replicates. c Quantification of adaptation time of Hog1 nuclear enrichment computed as in
Figure 1B. Values are normalized to the average WT. Error bars represent the SEM of n=3
biological replicates. *P¡0.05; two-sided Student’s t-test. d Measurement of internal
glycerol over time for the strains shown in Panel B in response to a step input of 1.2 M
sorbitol osmotic shock. Measurements are taken using a colorimetric assay. Inset: the
change in glycerol, calculated as the difference between two time points for data in Panel
D, is plotted as a function of time. Error bars represent the standard deviation for n=3
biological replicates.
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Figure 2.4: Cell cycle arrest mediates tradeoffs between fast recovery and resilience to mul-
tiple instances of osmotic shock.
a Top: experiment schematic representing a series of 1.2 M sorbitol osmotic shock
step inputs. The first input lasts for 90 minutes and subsequent inputs last 45 minutes,
and are separated by 5 minutes. b Time traces of Hog1 nuclear enrichment of WT (blue),
sic1∆ (orange). Shaded regions represent the SEM of n=3 biological replicates. c
Quantification of adaptation time of Hog1 nuclear enrichment for WT and sic1∆ strains
for data presented in Panel B. Values are normalized to the average first response for the
WT strain. Error bars represent the SEM of n=3 biological replicates. d The percent of
cells with altered morphological phenotypes at the end of each step input of 1.2 M sorbitol.
Error bars represent the SEM of n=3 biological replicates. **P¡0.005; two-sided Student’s
t-test. e Representative brightfield images corresponding to the timepoints quantified in
Panel D. Images depict the compromised cell wall morphology indicated by red arrows in
the WT (top) and sic1∆ (bottom) strains. f Conceptual model of the role of cell cycle
arrest in hyperosmotic shock response.
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2.12 Supplemental Data Figures
Figure 2.5: The sic1∆ mutant recovers faster following osmotic shock induced by 0.6 M
NaCl.
a Time traces of Hog1-mVenus nuclear enrichment for WT (blue) and sic1∆
(orange) in response to a 0.6 M NaCl step input. Shaded regions represent the SEM of n=3
biological replicates. b Quantification of Hog1 adaptation for WT (blue) and sic1∆
(orange). Values are normalized to the average WT. Error bars represent the SEM of n=3
biological replicates. *P¡0.05; two-sided Student’s t-test.
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Figure 2.6: WT glucose uptake rate is greater than sic1∆ by nearly three-fold in the presence
and absence of osmotic shock.
a Cartoon schematic of experiment to infer extracellular glucose uptake rates. At
time zero a 1 mL sample of cells was transferred to filter paper above a vacuum manifold
and continuously perfused with fully-labeled 13C glucose media with and without 1.2 M
sorbitol for durations of 10 s, 20 s, 30 s, 45 s, and 60 s and transferred to quenching
solution. b A schematic of central glycolysis and the glycerol branch of central metabolism
with the targeted metabolites featured. WT (blue) and sic1∆ (orange); solid lines
represent 1.2 M sorbitol osmotic shock, and dashed lines represent normal defined media.
Error bars represent the standard deviation of n=2 technical replicates. c Fitting an
exponential decay to each 12C enrichment over time trace, bar plots show the average
decay constant, which serves as a proxy for 13C incorporation rate, for each metabolite and
condition. The plotted constant represents the average of the n=2 technical replicates
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Figure 2.7: Average growth rate bears a weak correlation to average Hog1 adaptation time.
a OD600 readings of WT (blue), sic1∆ (orange), sic1∆nth1∆ (grey), sic1∆gph∆
(purple) ,sic1∆nth1∆gph1∆ (gold) and gph1∆ (green) strains with readings taken every 20
minutes over 24 hours. Shaded regions represent the SEM of at least n=2 biological
replicates. b The average growth rate of each strain measured in Panel A plotted against
its average adaptation time later shown in Supplemental Figure 5B. Error bars along each
axis represent the standard deviation of at least n=2 biological replicates. R, Pearson’s
correlation coefficient. P-value; Student’s t-test.
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Figure 2.8: Stress-induced mobilization of an internal carbon macromolecule is shunted into
central glycolysis in the sic1∆ mutant.
a Cartoon schematic of experiment to test internal carbon enrichment of targeted
metabolites. Five minutes prior to time zero, cells were resuspended in fully-labeled 13C
glucose. At time zero the culture of cells were diluted 1:1 in fully-labeled in 13C glucose
with either 2.4 M sorbitol or normal defined media. At the indicated time points, 1 mL of
culture was placed on filter paper above a vacuum manifold for the media to wash through,
and transferred to quenching solution. b. A schematic of central glycolysis and the glycerol
branch of central metabolism with the targeted metabolites featured. WT (blue) and
sic1∆ (orange); solid lines represent 1.2 M sorbitol osmotic shock, and dashed lines
represent normal defined media. Error bars represent the standard deviation of n=2
technical replicates.
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Figure 2.9: Knockout of glycogen catabolism enzyme, Gph1, is sufficient and necessary to
rescue accelerated phenotype conferred with removal of Sic1.
a Traces of Hog1 nuclear enrichment over time following 1.2 M sorbitol osmotic
shock in the WT (blue), sic1∆ (orange), sic1∆nth1∆ (grey), sic1∆gph1∆ (purple)
,sic1∆nth1∆gph1∆ (gold) and gph1∆ (green) cells. Shaded regions represent the SEM of
n=3 biological replicates. b. Quantification of adaptation time of Hog1 nuclear enrichment
computed as in Figure 1B. Values are normalized to the average WT. Shaded regions
represent the SEM of n=3 biological replicates. *P¡0.05; two-sided Student’s t-test.c
Quantification of internal glycerol as a function of time for WT (blue), sic1∆ (orange),
sic1∆nth1∆ (grey), sic1∆gph1∆ (purple) ,sic1∆nth1∆gph1∆ (gold) to a step input of 1.2
M sorbitol osmotic shock. Measurements are taken using a colorimetric assay. Error bars
represent the standard deviation for n=3 biological replicates. dThe change in glycerol,
calculated as the difference between two time points for data in Panel C, is plotted as a
function of time. Error bars represent the standard deviation for n=3 biological replicates.
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Figure 2.10: Multiple step inputs of osmotic shock reveal different susceptibilities between
rescue strains.
a Top: experiment schematic representing a series of 1.2 M sorbitol osmotic shock
step inputs. The first input lasts for 90 minutes and subsequent inputs last 45 minutes,
and are separated by 5 minutes. b. Time traces of Hog1 nuclear enrichment of WT (blue),
sic1∆ (orange), sic1∆gph1∆ (purple), sic1∆nth1∆gph1∆ (gold). Shaded regions represent
the SEM of n=3 biological replicates.c Quantification of adaptation time of Hog1 nuclear
enrichment for WT and sic1∆ strains for data presented in Panel B. Values are normalized
to the average first response for the WT strain. Error bars represent the SEM of n=3
biological replicates. dThe percent of cells with altered morphological phenotypes at the
end of each step input of 1.2 M sorbitol. Error bars represent the SEM of n=3 biological
replicates. **P¡0.005; two-sided Student’s t-test.
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2.12.1 Supplementary Information
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Chapter 3
A Toolkit for Rapid Modular
Construction of Biological Circuits in
Mammalian Cells
3.1 Abstract
The ability to rapidly assemble and prototype cellular circuits is vital for biological
research and its applications in biotechnology and medicine. Current methods for the
assembly of mammalian DNA circuits are laborious, slow and expensive. Here we present
the Mammalian ToolKit (MTK), a Golden Gate-based cloning toolkit for fast, reproducible
and versatile assembly of large DNA vectors and their implementation in mammalian
models. The MTK consists of a curated library of characterized, modular parts that can be
assembled into transcriptional units and further weaved into complex circuits. We
showcase the capabilities of the MTK by using it to generate single-integration landing
pads, create and deliver libraries of protein variants and sgRNAs, and iterate through
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dCas9-based prototype circuits. As a biological proof of concept, we demonstrate how the
MTK can speed the generation of non-infectious viral circuits to enable rapid testing of
pharmacological inhibitors of emerging BSL4 viruses that pose a major threat to human
health.
3.2 Introduction
Molecular cloning is the cornerstone of modern biological research, enabling the generation
of DNA vectors that encode a wide variety of molecules, which can further be organized
into genetic circuits with applications ranging from basic discovery to medical platforms.
To transform molecular cloning into a fast and reproducible engineering discipline, circuit
parts need to be modular, vetted for their function and easy to share. Furthermore, these
circuits need to be rapidly assembled, amenable to fast prototyping, and easily deliverable.
Conventional approaches to produce DNA vectors involve PCR amplification of DNA
fragments, which are ligated following digestion with restriction enzymes. This procedure is
time consuming, laborious, error-prone and requires sequencing control steps. Commercial
DNA synthesis provides a potential avenue to reliably build libraries of DNA vectors.
However, current pricing, size limitation, and turnaround time remain a significant
bottleneck. While in yeast and plant systems toolkits for rapid assembly of genetic circuits
from libraries of well described modular parts exist40–45, no similar comprehensive resource
exists for mammalian systems. Existing resources such as the Gibson modular assembly
platform (GMAP)46, and more recently, the Mammalian Modular Cloning (mMoClo)47
and Extensible Mammalian Modular Assembly kit (EMMA)48 provide a starting point for
developing this functionality. However, while these methods use sets of modular parts that
can be assembled directionally into transcription units (TUs), they have important
remaining shortcomings. GMAP requires sequencing in between all cloning steps, which for
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large DNA elements (such as a 7 kb viral polymerase) makes the method slow and
expensive since PCR reactions of such elements are difficult and prone to mutations, and
require, in the viral polymerase example, at least 7 sequencing reactions for every tested
clone. EMMA and mMoClo provide a method to hierarchically assemble DNA vectors that
encode large circuits, without the need of additional PCR and sequencing reactions.
However they both lack several characteristics that would make them useful for general
use. mMoClo, is not available in Addgene or upon request, making its adoption
unrealizable. EMMA, while available to users, lacks a library of tested parts for facile use
and integration of sgRNA cloning. EMMA also provides good flexibility in terms of part
building, but it has not been shown to be able to build circuits with more than 3
transcriptional units. Finally, because EMMA necessitates assembly of 25 parts to build
functional plasmids, a substantial energy barrier for its adoption in the community at large
seems to exist. In this work, we present a toolkit that capitalizes on the strengths of
previous efforts42,49, but substantially extends their capabilities for mammalian molecular
cloning, providing a first platform that can be immediately adopted by the community.
The Mammalian ToolKit (MTK) is a library of over 300 parts including vetted promoters,
3’UTRs, fluorescent proteins, insulator and P2A elements that can be rapidly combined to
build complex genetic circuits. To facilitate the MTK’s ease of use, users can consolidate
parts into ready-made, customizable destination vectors to bypass the need to re-assemble
multiple plasmids and often-used elements such as selection markers. These vectors can be
delivered to a wide range of cell types through viral, recombinase and CRISPR/Cas9
methods. Importantly, the MTK requires the assembly of only 8 unique parts for a
functional transcriptional unit, which in turn can be immediately used to build plasmids
carrying up to 9 transcriptional units that can encode the expression of a wide variety of
coding DNA sequences as well as of sgRNAs for targeting of Cas9 proteins of two species.
As a proof of concept, we built a hAAVS1 landing pad for single integration of genetic
circuits, created and delivered libraries of protein variants and sgRNAs and rapidly
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compared multi-species Cas9-based genetic circuits. Finally, using Ebola virus (EBOV) as
an example, we demonstrate how the MTK can simplify and speed the de novo generation
of non-infectious BSL2 stable cell line expression systems commonly deployed to facilitate
analyses of emerging BSL4 viruses.
3.3 An expansive, modular cloning toolkit for rapid
prototyping in mammalian cells
The basis for the MTK is a library of parts that are “domesticated” from source DNA
using a Golden Gate (GG) reaction10 into a standard vector. This requires designing oligos
that anneal to the source DNA, appending restriction sites that enable the resulting PCR
product to be digested and ligated into the base parts vector with chloramphenicol
resistance (MTK0 027). The resulting plasmid is then sequenced once to ensure fidelity to
the source sequence, and can later be reused as a validated modular part in a variety of
genetic constructs. Similar to previously published work42,47–49, we utilize the type-IIS
restriction enzymes BsaI and BsmBI with “reach over” endonuclease activity that leaves
arbitrary four base overhangs adjacent to the recognition site. The defining feature for a
part vector is a unique four base overhang that categorizes it to similar parts, and ensures
an ordered 5’ to 3’ ligation of parts into a transcriptional unit (TU) of multiple parts. We
used the same overhangs as defined in the Yeast Toolkit (YTK)42. These overhangs have
been shown to enable highly efficient assemblies and, because the YTK has reached a wide
community of users, parts that have been built for the YTK can be reused in the MTK.
With a library of sequenced-verified part vectors, only diagnostic restriction digests are
necessary to verify correct assembly in subsequent GG reactions. We employ BsmBI and
BsaI GG reactions in an alternating manner to assemble a library of part vectors into
libraries of TU plasmids, and ultimately into multi-transcriptional unit (multi-TU)
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plasmids. Like part vectors, TUs have unique overhangs that define their position in a
multi-TU plasmid. The time from initial source DNA to final plasmid product is four days,
assuming the use of fast growing E. coli and 18h for sequencing turnaround(Fig.3.1a).
However, once MTK plasmid parts are constructed, they can be reused to assemble new
configurations in only two days. This is a substantial gain for a general, non-specialist, user
who can achieve many complex circuits already from the large library of parts that the
MTK provides.
The MTK encompasses part vector categories 1-8 that are sufficient to build and
deliver a vast combinatorial library of genetic constructs to cells (Fig.3.1b). Parts 2, 3 and 4
form the core of a TU, specifying the 5’ UTR, coding, and 3’ UTR sequences, respectively.
Part 2 corresponds to promoter sequences that can be specified to drive constitutive or
inducible expression or recruit diverse polymerases. Part 3 vectors are canonical coding
sequences that are typically proteins of interest. Part 4 corresponds to 3’ UTR sequences
that can encode polyadenylation (pA) sequences that terminate transcription or spacer
sequences that couple transcription to the downstream TU. Parts 1 and 5 correspond to
connector sequences that enable the sequential ordering of TUs into a multi-TU plasmid,
with many versions provided in the MTK. For example, Part 1 implements connectors with
insulator sequences50 to minimize polymerase read-through between TUs or connectors
with cis-acting P2A elements to enable strongly correlated expression from one promoter
driving up to five downstream TUs51,52. Overall, the connectors included in the MTK allow
the construction of multi-TU plasmids encoding 9 TUs, and hence large genetic circuits.
Further nested subdivision can be achieved — for example Part 3 can be replaced with
Part 3a and 3b, and still connect to a Part 4, allowing for combinations that implement
tethering of localization tags, protein domains or any desired coding sequence both N- and
C-terminally with an innocuous linker sequence in between (Fig. 1b). Additionally,
coupled Part 234 vectors accommodate rapid cloning of small guide RNA (sgRNA)
expression by oligo annealing for CRISPR/Cas9-related genetic constructs. Parts 6, 7 and
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8 generally flank a typical TU and can encode the method of delivery to cells, such as
homology arms for a locus of integration. Lastly, the MTK contains kanamycin resistant
Part 0 destination vectors that allow delivery via viral transduction, transposase
transfection53,54 and homologous recombination from the same, recyclable collection of TUs
(Fig.3.1c). Only Part 0 in the final GG reaction needs to be changed in order to
accommodate different delivery methods into cells. Overall, the MTK combines intuitive
organization with an expansive library (345 parts listed in Supp. Table 1 and publicly
available on Addgene) for rapid facile construction of genetic constructs that can be
integrated into cells without redesign or re-sequencing, irrespective of the delivery method.
3.4 MTK enables facile construction of independent
or multicistronic TUs with different levels of
expression
The MTK contains seventeen characterized constitutive promoters derived from a mix of
human, mouse and viral55 origin, and two inducible promoters whose use is illustrated in
Fig.5. This set provides a range of expression levels, and a balance of native and transgene
promoters for the two conventional cell lines tested. To enable matching expression levels
of different proteins without re-using the same promoter, this panel also includes select
promoters that closely match each other. To characterize the relative strengths of these
promoters we assembled a panel of 14 TUs with varied promoter parts driving
mAzamiGreen expression, flanked by the bovine growth hormone (Bgh) pA 3’ UTR. An
insulated downstream TU, where a CAG promoter expresses mScarlet with the rabbit
beta-globin (Rgl) pA 3’ UTR (Fig.3.2a), was used for normalization. Transient transfection
in HEK293T cells demonstrated that this suite of promoters spanned a smooth continuum
42
of 2 orders of magnitude over background, with the strongest promoter, CMV, more than
300-fold greater than a promoter-less mAzamiGreen (Fig.3.2a). The relative strengths of
these promoters was largely maintained across human and mouse cell lines (Supplementary
Fig.3.7a,3.7b), suggesting that they are portable across commonly used cell lines.
Additionally, the rank of promoter expression was consistent between transient and stably
integrated expression (Supplementary Fig.3.7c,3.7d). The MTK provides options for
further fine-tuning of TU expression using a collection of five different 3’ UTR sequences.
Similar to the promoter comparison, we generated a circuit with the same constitutive
promoter (EF1a) and varied the 3’ UTR sequence to compare normalized mAzamiGreen
expression (Fig.3.2b). We observed a range of 4-fold change in expression of mAzamiGreen
among the three conventional 3’ UTR sequences. While the Bgh pA and Rgl pA signals
have the same effect on gene expression, the simian virus 40 (SV40) pA signal had a nearly
1.5-fold greater effect (Fig.3.2c). Moreover, replacing a canonical 3’ UTR sequence with
either a spacer sequence with a stop codon (used for lentiviral delivery) or without a stop
codon (used for multicistronic read-through) diminished expression of its upstream coding
sequence. While we explored here only a few combinations related to one promoter (EF1a),
libraries of fine-tuned expression of a protein of interest can be easily generated using this
platform by the interested user. Finally, to enable concomitant expression of up to 6 TUs
in a multicistronic vector, we incorporated ribosome skipping P2A elements51,52 into the
MTK part 1. We used this part to build a vector with one CAG promoter driving
membrane-tethered iRFP713, cytoplasmic mAzamiGreen, mCerulean-tagged p38KTR56,
and histone H2B fused to mScarlet separated by P2A elements, and compared expression
from this construct to a parallel multi-TU construct (Fig.3.2c). The multicistronic
construct conferred a 35% reduction in vector size (15540 bp to 10020 bp) compared to the
multi-TU construct yet maintained the correct localization of each of the proteins in
transiently transfected HEK293T cells (Fig.3.2d). These data demonstrate the opportunity
to deploy P2A elements to generate multicistronic expression constructs to circumvent the
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size limitations of conventional viral delivery vectors.
3.5 MTK contains a landing pad system and
accompanying destination vector
When delivering synthetic genetic circuits, it can be essential to have site-specific and
reliable single copy integration. Therefore, the MTK includes a BxBI-dependent landing
pad (LP) system for integrating synthetic circuits in a locus of choice. This system is
divided into two parts: an LP cell line and an LP transfer vector. The LP transfer vector
can be used with MTK generated LP cell lines, as well as cell lines carrying the SBI
pinpoint system landing pad, or that were generated using other methods and that contain
a BxBI attB site47. We used a CRISPR/Cas9 approach to build a HEK293T cell line with
a BxBI landing site in the well-characterized adeno-associated virus integration site 1
locus57,58 (hAAVS1 LP) and tested its ability for site-specific recombination. The vector
used encoded a multicistronic cassette with hygromycin resistance and nuclear-localized
mRuby2. The BxBI attP site was located between the promoter and the first gene of this
cassette (Fig.3.3a). We verified the correct integration of the LP cassette by PCR in 8
clones (Supplementary Fig.3.93) and continued its characterization in clone 8 with a
monoallelic LP. We further confirmed the presence of the LP in the cell line by mRuby2
expression (Fig.3.3b). In order to verify that the transfer vector was correctly integrated in
the LP, we positioned a promoter-less multicistronic cassette encoding blasticidin resistance
and nuclear localized tagBFP downstream of the BxBI attB site. When site-specific
integration is accomplished, the cell line switches fluorophore (from mRuby2 to tagBFP)
and resistance (hygromycin to blasticidin). To test the landing pad, we integrated a
transcriptional unit that expresses H2B mAzamiGreen-fused histone H2B from the CAG
promoter (Fig.3.3, Supplementary Fig.3.3b). Upon integration of the transfer vector into
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the hAAVS1 LP, we noted the decrease in mRuby2 expression together with expression of
mAzamiGreen and tagBFP in most cells (Fig.3.3b, Supplementary Fig.3.3b), with a small
fraction of cells showing no or incorrect integration of the transfer vector. Finally, while we
chose to integrate the landing pad in one genomic locus, others can be easily targeted by
replacing the homology arms in the CRISPR/Cas9 vector.
3.6 MTK allows rapid, one step combinatorial
construction of libraries
The inherent modularity of the MTK workflow facilitates parallelization of large libraries of
vectors in one-step combinatorial reactions. Moreover, such libraries can be reused and
delivered repeatedly and in multiple ways. These features are particularly relevant for
optimization of a large number of protein or circuit variants or CRISPR/Cas9 screens
where efficient throughput and variant representation are critical. Here, we provide two
examples of MTK combinatorial library construction that illustrate how it can be applied
to streamline the generation of large libraries of TU variants. First, a library of fluorescent
proteins that vary in their localization, and which can be integrated as a single-copy into
the BxBI landing pad site; second, a library of viral-delivered sgRNAs that target Cas9 to
two fluorescent proteins leading to their disruption. In the first library, we combined one of
three localization tags (NLS (nucleus), NES (cytoplasm) and Lyn (plasma membrane))
with four fluorescent proteins (tagBFP, mAzamiGreen, mScarlet and iRFP713) (Fig.3.4a).
Performed in parallel, this reaction generated 4 fluorescent variants per localization tag.
These libraries of variants were further pooled in equimolar amounts with a LP destination
vector. This single reaction was predicted to create a library of 64 distinct variants, where
each vector in the library encodes three random fluorescent proteins that are localized in
the nucleus, cytoplasm and plasma membrane. The final library was delivered to the
45
hAAVS1-LP HEK293T cell line described before (Fig.3.4). Visualization of expression and
localization of the fluorescent proteins after selection with blasticidin showed a qualitative
assortment of random, single fluorescent markers located in the three subcellular
compartments, (Fig.3.4b) as predicted from the cloning strategy. While other Golden
Gate-based toolkits have the ability to generate combinatorial libraries of proteins, they
cannot generate combinatorial libraries of sgRNAs. Such libraries are useful for targeting a
combination of genes, either with Cas9 or with a wide variety of modified dCas9 variants.
To address this need, we showcased the ability of the MTK to generate sgRNA
combinatorial libraries by building a library of sgRNAs that target two fluorescent proteins.
We first assembled TUs that contain sgRNAs that target tagBFP, mScarlet, or that are
non-targeting59. We combined those in a multi-TU unit so that a final Lentiviral delivery
plasmid contained 2 guide RNAs, ensuring that we had any one of four possible outcomes
(knockout of tagBFP, mScarlet, tagBFP and mScarlet, or no knockout) in the final library
(Fig.3.4c). Each multi-TU encoded iRFP713 to facilitate the identification of cells that
express sgRNAs. Since sgRNA targeting has variable efficiency60, we concurrently
generated four individual lentiviral plasmids for the four outcomes of the library as a
control to compare the results of the combinatorial assembly. We independently transduced
the four control viruses in HEK293T cells expressing tagBFP, mScarlet and spCas9 (3C
cell line) and quantified tagBFP and mScarlet expression two weeks after transduction.
Cells that contained the non-targeting sgRNAs expressed high levels of both tagBFP and
mScarlet (Fig.3.4d, first panel). Cells expressing the tagBFP-targeting sgRNA showed
reduced expression of tagBFP in 86% of the population (Fig.3.4d, second panel), while
only 27% of cells showed reduced expression of mScarlet when its guide was expressed
(Fig.3.4d, third panel). Accordingly, when both guides were co-expressed, only 31% cells
show reduced expression for both proteins, while most cells had reduced tagBFP (Fig.3.4d,
fourth panel). We used these results to build a linear classifier, trained on the individual
targeted variants of sgRNA to determine the likely sgRNAs that each cell received in a
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population transduced with the full sgRNA library. Due to the inefficient targeting of the
mScarlet guide, the linear classifier had an average precision of 0.62 and an average recall
of 0.58 (Fig.3.4e, Supplementary Fig.3.10) and predicted higher than expected proportions
of non-targeting and tagBFP sgRNA-expressing cells when presented with an equal
proportion of each variant of the library (Fig.3.4f). To test the combinatorial assembly
approach, we transduced the 3C cells with 4 biological replicates of the sgRNA library.
After 14 days of selection, we measured tagBFP and mScarlet expression and identified
cells belonging to the four possible outcomes of the viral library, suggesting that all
combinatorial possibilities are achievable through this method (Fig.3.4g). Importantly, the
fraction of each outcome was in accordance with the predictions of the classifier, indicating
that the MTK is able to rapidly generate libraries for combinatorial exploration of proteins
variants or sgRNAs that maintain the correct ratio of variants.
3.7 MTK facilitates optimization of combinatorial
gene circuits for synthetic biology applications
To capitalize on the potential of the MTK for parallel testing of combinatorial circuits, we
constitutively expressed deactivated Streptococcus pyogenes and Streptococcus aureus
CRISPR Cas9 (dSpCas9 and dSaCas9, respectively) C-terminally fused to either a
fluorescent protein (FP), repressor domain (Kru¨ppel associated box, KRAB), or an
activator domain (VP64-p65-Rta, VPR)61–65. These protein-effector combinations were
targeted to two inducible promoters included in the MTK: the GAL4 Upstream Activating
Sequence (UAS) or the Tet Responsive Element (TRE) (Fig.3.6a). Each gene circuit was
assembled upstream of a constant TU control with constitutive EF1a expression of
iRFP713. In total, we transiently transfected twelve different circuits into HEK293T cells
and normalized changes in mAzamiGreen expression by iRFP713. The plasmids encoding
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these circuits have an average size of 16kbp. While our parallel building protocol required
only 2 test restriction enzyme digestions to verify the correct assembly of the circuits,
methods based on gibson assembly would have required about 200 sequencing reactions (12
circuits, sequencing 14kbp of each one) for sequence verification of the 12 circuits
assembled from 9 PCR products. As expected, in each of the circuit iterations, expression
of mAzamiGreen relative to the iRFP713 control was below basal with the repressor
domain, or above basal with the activator domain (Fig.3.6b). dSpCas9 achieved
approximately 3-fold reduction in fluorescence through the KRAB effector and 30-fold
induction in both the UAS and TRE promoters. In contrast, the dSaCas9 fused to VPR
was an effective activator, increasing expression 30-fold, but when fused to a KRAB
domain, dSaCas9-mediated repression was comparable to background FP expression levels.
The TRE promoter exhibited higher basal activity due to its overall greater repression, and
lower activation when compared to the UAS promoter. This information expedites the
rational design of dCas9-based gene circuits and can be easily scaled to screen and
customize various combinations of genetic circuits.
3.8 MTK streamlines the generation of endogenous
viral circuits
Viruses represent a class of naturally occurring genetic circuits that are particularly
amenable to MTK construction due to their modular genome organization. As such, the
MTK provides virologists the opportunity to rapidly “boot up” the genes, replicons, or the
complete life cycles of emerging viral agents as soon as their sequences are available. A key
example corresponds to the filoviruses, a family of emerging highly pathogenic (BSL4)
RNA viruses that includes the Ebola viruses66. Global efforts to contain filovirus outbreaks
have resulted in several candidate vaccines and antivirals; however, there is currently no
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approved preventive or therapeutic treatment. A challenge to advancing our understanding
of EBOV was its highly pathogenic nature and the need for BSL4 containment. In the late
1990’s a BSL2 system was developed for Zaire Ebola virus (ZEBOV) to facilitate research
on its transcription and genome replication sub-lifecycle and antiviral discovery efforts67,68.
However, this system requires transient transfection of 6 plasmids (four viral proteins (NP,
VP35, VP30, and Lpol), T7 polymerase, and a T7-driven minigenome reporter
construct67) (Fig.??a). The complexity and variability of this system has limited feasibility
to perform industrial scale compound screening campaigns to identify effective inhibitors of
EBOV. More recently, a robust stable ZEBOV RNP cell line system was developed via
sequential integration of RNP viral proteins69; however, this approach entailed a
time-intensive, multi-step approach that took 1 month. This timescale is undesirable if the
goal is to enable rapid investigation of emerging viruses or variants of the same virus.
Given the urgent need and time sensitive nature that outbreaks of highly pathogenic
emerging viral agents pose to human health, we explored how the MTK workflow can
streamline and improve the de novo generation of BSL2 tools like the EBOV RNP
minigenome replicon system. We used the MTK system to design a single 4-cistronic
construct of Zaire ebolavirus (ZEBOV-4cis, Fig.??a) directly and simultaneously into five
different Part 0 destination vectors (Supplementary Fig. S5a). In transient transfections,
all variants of the ZEBOV-4cis constructs displayed levels of minigenome activity similar to
the 6-plasmid system, with 40-60-fold higher activity than cells lacking the viral
polymerase Lpol. All five of these systems showed robust cell viability (Fig.??b,
Supplementary Fig.3.11b). Stable cell lines harboring the ZEBOV-4cis construct were
generated using PiggyBac transposon-mediated integration in 10 days followed by isolation
of clonal cells (Fig.??c, Supplementary Fig.3.11c). Comparable viability and minigenome
reporter activity were observed in two independent ZEBOV-4cis stable populations and
clonal cell lines (Fig.??d). The P2A ribosome skipping sites encoded in the ZEBOV-4cis
construct confer 2A peptide tags at the C-terminus of each of the NP, VP35, and VP30
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proteins, enabling the simultaneous detection of all 3 proteins with a 2A peptide antibody
(Fig.??e). Larger multi-ORF fusion protein products were not detected with the 2A
peptide antibodies or NP and VP35 antibodies, indicating efficient “self-cleavage” occurs at
each of the P2A sites. As expected, VP35 showed diminished expression, probably due to
the known effect of P2A elements on downstream peptides. This is a trait that may be
desirable in certain systems such as viruses that regulate expression levels of downstream
genes70. Parallel immunofluorescence analysis showed a punctate cytoplasmic localization
pattern (Fig.??f) consistent with previously described ZEBOV inclusion bodies that
correspond to sites of viral replication71–73. A lack of available specific antibodies or 2A tag
encoded in the Lpol gene made parallel protein expression analyses infeasible for Lpol;
however the Lpol dependence of minigenome activity in this system (Fig.??b and ??c)
provides confirmation of functional Lpol expression. We also examined the susceptibility of
the ZEBOV-4cis stable cells to previously described small molecule inhibitors: Gedunin, an
inhibitor of heat shock protein 90, and 6-Azauridine, a nucleoside analog74,75. Treatment of
ZEBOV-4cis stable cells with 5 µM of each compound revealed ¿50% inhibition of
minigenome activity, with minimal impact on cell viability (Fig.??g). These data indicate
that the ZEBOV-4cis stable cell lines generated here are similarly susceptible to known
inhibitors identified in transient RNP minigenome systems or recombinant virus
systems74,75. Taken together, these data demonstrate that the MTK workflow facilitates
rapid generation of BSL2 systems to study filoviruses and other viral agents as they
emerge, providing a critical opportunity to increase the throughput and the rate at which
we can screen for and identify candidate antiviral compounds.
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3.9 Discussion
A key element of cellular engineering is the ability to quickly build, test, and iterate on
designs. This is currently infeasible in mammalian cells using conventional methods in
molecular cloning. Here, we presented the MTK, a platform that takes an important step
to remove bottlenecks in mammalian cellular engineering. A major asset of the MTK is a
large, characterized suite of modular parts to build versatile TUs, which we showcased by
driving different levels of gene expression for single TUs and creating multicistronic
constructs. Additionally, we included lentiviral, recombinase and Cas9 delivery vectors to
maximize the number of contexts where circuits can be implemented. Due to the
modularity of the MTK, it is straightforward to generate new variants of delivery vectors,
which we demonstrated by creating BxBI Landing Pad for the hAAVS1 locus. The set of
validated, interchangeable parts of MTK constitute fundamental tools for the rapid and
facile assembly of genetic circuits. We illustrated this point in two ways: first, we
assembled a combinatorial library of transcriptional units that encode different proteins or
guide RNAs; second, we combinatorially assembled new circuits that use different MTK
parts. Such libraries are generated through the MTK in a straightforward way, reproducing
all variants included in the combinatorial assembly process and maintaining their ratios
through all the cloning steps. While these studies tackled a small set of applications, many
new combinatorial libraries can be built with any parts in the MTK as it currently exists,
or as users add to its parts. For example, introducing a panel of C-terminal fluorescent
protein tags into the MTK would only require a one-time PCR and sequence verification
for each tag to “domesticate” the series as 4a Parts. Additionally, the facile assembly of
sgRNAs expedites the production of expression vectors that are easily amenable to
CRISPR screens of all scales. With the many reagents encoded in the MTK library, diverse
TUs with multiple functions can be rapidly assembled, screened and repurposed to generate
a wide array of final circuit vectors. The capabilities provided in the MTK are particularly
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relevant in the context of infectious disease outbreaks where time is of the essence.
Responding to and containing such outbreaks is an important public health challenge that
demands rapid production and iteration of viral circuits in mammalian cells to enable
discovery of inhibitors and analysis of their basic biology. Using ZEBOV as an example, we
demonstrated how the MTK can reduce the lead time needed to generate functional
reagents and respond to outbreaks of highly pathogenic viruses. We generated functional
cell lines stably expressing the ZEBOV replication complex components in days, while
maintaining a library of these components for diverse future applications. Furthermore,
given that discovery or availability of a virus sequence does not necessarily correlate with
successful culturing of the virus in a lab76, the MTK system provides a powerful and
parallelizable method to rapidly test multiple viral strains and primary clinical isolates, as
well as engineered variants of each of these that are optimized for expression in cell culture.
While this presents a scaling challenge for conventional cloning approaches, the MTK
workflow enables faster iteration and identification of optimal viral circuits for downstream
analyses. Thus, the MTK presents a tool for virologists to begin to scale functional
experimental studies apace with the recent explosive growth in viral genome sequences77,78.
Finally, while not explored in this work, the MTK constitutes a launching platform for
additional exciting capabilities, including the incorporation of barcoding capabilities for
bulk and single-cell sequencing technologies79–81, enhanced flexibility in genetic circuit
design82, and automation to streamline assembly. These advances are poised to position
the MTK as a major catalyst for biological research and biotechnology.
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3.10 Methods
Bacterial Cell Culture
Commercial MachI and XL10 strains (QB3 MacroLab) were used to transform plasmid
vectors. A typical transformation mixture consists of 2 µL of the Golden Gate reaction
product, 48 µL bacteria, incubated on ice for 30 minutes, heat shocked at 42°C for 1
minute, recovered on ice for 5 minutes, reaction mixture plated onto selective agar and
incubated overnight at 37°C. In the case of multi-TU transformations, cells recovered in LB
media for 30 min after heat shock at 37°C before plating reaction onto kanamycin selective
agar plates. Cells were cultured in antibiotic concentrations of 100µg/mL chloramphenicol,
25µg/mL carbenicillin and 100µg/mL kanamycin.
Golden Gate Reactions The general reaction mixture follows 0.5 µL per PCR
product, annealed oligos, geneblock, or plasmid (50 fmol.µL-1); 1 µL T4 DNA Ligase
Buffer (10x) (NEB) with 0.25% PEG; 0.5 µL T4 DNA Ligase (NEB) diluted with water to
a total volume of 9.5 µL. For BsaI GG reactions, we added 0.5 µL BsaI-HFv2 (NEB
R3733). For BsmBI GG reactions we used 0.5 µL of either BsmBI (NEB) or FastDigest
Esp3I (Thermo Scientific FD0454 NEB) (both 10,000 U/mL).
Thermocycler protocols The GG protocol is primarily used for assembly
reactions. The reaction temperature is initially held at 45°C for 2 min to digest the
plasmids followed by 20°C for 4 min to anneal constituent parts together. After repeating
these first two steps 24 times, the temperature is increased to 60°C for 10 min to digest
remaining recognition sites and inactivate the ligase. Then the temperature is held at 80°C
for 10 min to inactivate the enzyme. Lastly, the reaction is held at 12°C indefinitely. The
“GG End-On” protocol is used when BsaI or BsmBI sites need to be retained in the final
product. The temperature is initially held at 45°C for 2 min to digest the plasmid followed
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by 20°C for 5 min to anneal and ligate the resulting plasmid. These steps are cycled 24
times and then held at 16°C indefinitely.
Domestication of Parts Forward and reverse primers ordered from IDT
(www.idtdna.com) were manually designed to anneal to source DNA. See Supplementary
Table 3 for part-specific design of domestication primers. In summary, internal BsaI and
BsmBI sites were removed and tandem BsaI and BsmBI sites were appended to both the 5’
and 3’ ends of the sequence (See Supplemental Tables 3 and 4). PCR was performed with
the general reaction mixture of 10 µL Q5 polymerase master mix (NEB MO492S) using 1
µL each of the forward and reverse primers (10 µM) and 0.5 µL of template DNA. The
desired PCR product was gel extracted (ThermoFisher Gel Extraction K0691) and 1 µL of
the final elution added to a BsmBI-mediated GG reaction (described above) with the
MTK0 027 domestication vector. The resulting product was transformed into bacteria and
grown in selective LB overnight. Plasmid DNA was extracted (ThermoFisher MiniPrep
K0503) and sequenced verified.
Removal of Internal BsaI and BsmBI Sites To remove an internal BsaI or
BsmBI site when domesticating a coding DNA sequence part, overlapping forward and
reverse primers are designed at the restriction site with a synonymous mutation made to
ablate the internal site while preserving the coded amino acid. For non coding parts,
substitutions were made to maintain CG content when possible. Flanking the site are
complementary BsmBI overhangs such that upon digestion of the resulting PCR products,
the components anneal together.
Oligo Annealing Oligos were designed such that the desired sequence was at
least 15bp long, and that when complemented the oligos generated the overhangs
associated with the part number. To anneal oligos into double stranded DNA, we prepared
a reaction mixture as follows: 1 µL of each oligo (100 µM), 1 µL T4 Ligase Buffer (NEB), 1
µL T4 PNK (NEB), 6 µL water. Mixture was incubated at 37°C for 1 hr and then diluted
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to a volume of 200 µL. To anneal the oligos, a thermocycler protocol was prepared to hold
the temperature of the reaction at 96°C for 6 min, and ramp down 0.1°C per second to
23°C. The reaction is then held at 23°C indefinitely. In the case of sgRNA design, this final
mix is then added to a BsmbI-mediated GG reaction into its corresponding sgRNA
destination vector. In the case of multi-oligo assembly, each oligo is added to the reaction
mixture with MTK0 027 in a BsmBI-mediated GG reaction as described above.
Geneblocks Gene fragments were ordered from IDT as either whole constructs
or partial constructs with complementary overhangs to ensure proper domestication.
TU assembly Part 1-5 plasmids were pooled together with a recipient Part 678
plasmid following a 2:1 molar ratio in a BsaI-mediated GG reaction as described above.
MTU assembly Constituent transcriptional unit plasmids were pooled in a 2:1
molar ratio with the destination vector in a BsmBI-mediated GG reaction as described
above.
Mammalian Cell Culture and Transfection
HEK293T and 3T3 cells were maintained in DMEM (Dulbecco’s Modified Eagle Medium,
Gibco) supplemented with 10% Fetal Calf Serum (SAFC) and passaged every 3 days.
Clonal cell lines of 293T cells carrying BxBI landing pad were obtained by single cell
sorting (FACS Aria2) of cells expressing mRuby2, following transfection of parental cells
with plasmids carrying CAS9 and 3 guide RNAs for hAAVS1(JPF0432) and landing pad
(MTK0 057). Transfections for transient expression were done in quadruplicate, in 96 well
(5.104 cells, 300ng total plasmid DNA) or 6 well plate (1.105 cells, 4ug total plasmid DNA)
format with Lipofectamine 2000 (Invitrogen), according to manufacturer’s instructions.
CAS9, Piggybac and BxBI transfections were performed in triplicate with Lipofectamine
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2000, according to the manufacturer’s instructions. In summary, transfections were
performed with 1:1 ratio of CAS9/transposase/recombinase (JPF0432 / pCMV-hyPBase /
pCAG-NLS-HA-Bxb1) to transfer vector, for a total of 800ng of DNA per well in 24 well
plates seeded with 5.104 cells. The next day following transfection, media was replaced
with normal growth media with the appropriate antibiotic selection. Hygromycin
(100ug/mL, Invivogen) and Blasticidin (10ug/mL, Neta Scientific) selection was performed
for at least 7 days, with media changes every 48h. pCMV-hyPBase was a gift from Wendell
Lim and pCAG-NLS-HA-Bxb1 was a gift from Pawel Pelczar (Addgene plasmid 51271 ;
http://n2t.net/addgene:51271 ; RRID:Addgene 51271).
Transfections for Zaire ebolavirus RNP assays were performed in duplicate or
triplicate using standard calcium phosphate transfection methods. Briefly, complexes were
generated in 100 µL of 1X Hepes Buffered Saline (HBS) (Thermo AAJ62623AK) and 12.5
µL of 2M calcium chloride (Fisher Scientific 50995817) per 1 µg of DNA for 15 mins at
room temperature prior to transfection of cells.
Lentiviral Production
For lentiviral generation, 24h before transfection, 5E5 HEK293T cells were plated in a 6
well plate containing 2mL of growth media. To prepare virus, transfections of 4ug total
DNA of equimolar amounts of of pCMV-dR8.91, pCMV-VSV-G, and transfer vector were
performed using Lipofectamine 2000, and following the manufacturer’s instructions. Media
was changed after 16h and virus were collected 48h after transfection, by filtering the
supernatant through a 0.45µm filter (Millipore SLHV033RS). For transductions, 24 h
before addition of virus target cells were seeded at a density of 1E5 in a 6 well plate and
transduced with 1 mL, 100 µL or 10 µL of viral supernatant supplemented with 4ug/mL of
polybrene (SCBT sc-134220). pMD2.G was a gift from Didier Trono (Addgene plasmid
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12259 ; http://n2t.net/addgene:12259 ; RRID:Addgene 12259) and pCMV-dR8.91 was a
gift from Wendell Lim
Flow Cytometry and Data Analysis
For the analysis of promoter, 3’UTR expression and hAAVS1 LP expression, cells were
collected in 96 well plates (Corning) and measured using an LSR2 flow cytometer (BD)
with the four laser configuration (488 nm, 635 nm, 355 nm, 405 nm). mAzamiGreen
(excitation at 488 nm, emission at 530 nm), mRuby2 or mScarlet (excitation at 561 nm,
emission between 610 and 620 nm) and tagBFP (excitation at 355 nm, emission at 450 nm)
fluorescence levels were recorded for 10000 events. Gating of single cells, normalization of
fluorescence levels, and statistical analysis was performed with custom python scripts
(https://github.com/jpfon/MTK).
Microscopy and Image Processing
For the imaging of combinatorial assembly of the fluorescent protein and localization tags
library, 5E4 HEK293T cells were plated in an 8-Well µ-Slide (Ibidi) that contains 200µL of
growth media. After 24h and before imaging, growth media was replaced with 200µL of
Fluorobrite DMEM (Gibco). Imaging was performed in a temperature and atmosphere
controlled chamber on a Zeiss microscope equipped with a Yokagawa CSUX1-A1N-E
confocal spinning disk. Images were collected with a 40 x 1.1 NA water immersion
objective and Photometrics Evolve 512 EMCCD camera. Images were stitched (ZEN,
Zeiss) and gamma-corrected (FIJI) for perception enhancement. For the imaging of
multicistronic fluorescent proteins, 45E4 HEK293T cells were plated in 8-Well µ-Slide
(Ibidi) containing 200µL of growth media. Imaging was performed in a temperature and
atmosphere controlled chamber on a Nikon Ti Microscope equipped with a Andor Borealis
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CSU-W1 confocal spinning disk. Images were collected through a 20x 0.75NA air objective,
using an Andor 4 Laser Launch for tagBFP (excitation at 405nm, collection between 425
and 475nm), mAzamiGreen (excitation at 488nm, collection between 500 and 550nm),
mScarlet (excitation at 561nm, collection between 590 and 650nm) and iRFP713
(excitation at 640nm, collection between 665 and 736nm). An Andor Zyla 4.2 sCMOS was
used to detect the images and pixel size was 325nm.
Viral DNA sequences and Plasmids
Synthetic cDNA sequences for viral NP, VP35, VP30, and Lpol from Zaire ebolavirus
Mayinga 1976 isolate (Accession: NC 002549, H.sapiens-tc/COD/1976/Yambuku-Mayinga)
were codon optimized (NP, VP35, VP30) and synthesized by IDT, followed by Gibson
assembly into the pCAGGs vector backbone. These yielded pCAGGs-NP, pCAGGs-VP35,
pCAGGs-VP30, and pCAGGs-Lpol expression plasmids. In order to generate the
4-cistronic (ZEBOV-4cis), viral proteins were PCR amplified from pCAGGs expression
vectors and domesticated into MTK0 027 entry vector using the BsmbI site followed by
verification with Sanger sequencing. The T7-driven viral minigenome construct
p2.0 3E5E eGFP was a gift from Elke Mu¨hlberger (Addgene plasmid 69359 ;
http://n2t.net/addgene:69359; RRID Addgene 69359), which was modified via NdeI and
NotI restriction sites to generate p2.0-3E5E-nLuc. T7opt in pCAGGS was a gift from
Benhur Lee (Addgene plasmid 65974; http://n2t.net/addgene:65974 ;
RRID Addgene 65974).
Compounds
Gedunin (CAS 2753-30-2) (Fisher Scientific 33871) and 6-Azauridine (Sigma A1882-1G)
were resuspended in DMSO to generate a 1mM stock solution. Stock solutions were serially
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diluted in DMSO and media to treat cells with a final concentration of 5µM in 1% DMSO.
Generation of ZEBOV-4cis stable cell populations and clones
HEK293T cells were seeded in 6-well plates at a density of 0.4E6 cells/well for 24 hours
and then transfected with 2 µg of total DNA (1 µg of MTK043-ZEBOV-4cis construct and
1 µg of PiggyBac transposon expression construct (pCMV-hyPBase)) using calcium
phosphate transfection. After 2 days cells were transferred to a 10-cm dish to begin
selection with hygromycin B (0.4 mg/mL) (Fisher Scientific MIR5930). Complete selection
was observed in 7 days resulting in ZEBOV-4cis expressing stable populations from which
clones were isolated using limited dilution plating. Briefly, cells were plated into 96-well
plates at a density of 0.5 cells/well in the presence of hygromycin for 10 days and
subsequently expanded to yield stable clones.
3.10.1 Western blot and Immunofluorescence analyses
Cell lysates were prepared in RIPA lysis and extraction buffer (Thermo 89900) containing
protease inhibitors (Sigma P8340) for Western blotting. Lysates were resolved by
SDS-polyacrylamide gel electrophoresis (PAGE), transferred to a polyvinylidene difluoride
(PVDF) membrane, and subjected to Western blotting using primary antibodies: rabbit
polyclonal Zaire ebolavirus NP (IBT Bioservices 0301-045) (1:1000 dilution), mouse
monoclonal Zaire ebolavirus VP35 (Kerafast EMS702) (1:1000 dilution), mouse
monoclonal 2A peptide (Novus Biologicals NBP2-59627) (1:2000 dilution), Rabbit
polyclonal GAPDH (Thermo Fisher Scientific PA1-987) (1:5000 dilution), and secondary
antibodies: goat anti-rabbit or goat anti-mouse polyclonal IRDye-800CW antibodies
(VWR, 1:5000 dilution). For immunofluorescence analysis, cells seeded in 12-well tissue
culture plates for 24 h were fixed in 4% formaldehyde for 20 min, incubated in
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permeabilization buffer (1% [vol/vol] Triton X-100 and 0.1% [wt/vol] sodium citrate in
PBS) for 10 min and then in blocking buffer (1% [vol/vol] Triton X-100, 0.5% [vol/vol]
Tween 20, and 3% bovine serum albumin in PBS) for 30 min. Cells were then incubated
overnight with primary antibodies for Zaire ebolavirus VP35 or 2A peptide, secondary
antibodies goat anti-mouse or goat anti-rabbit Alexa-488 for 30 min, and stained with
DAPI solution (GeneTex GTX16206) for 10 mins. Cells were imaged at 10X (Leica light
microscope).
3.10.2 Minigenome reporter assays (luciferase, GFP)
ZEBOV minigenome reporter construct (p2.0-3E5E-nLuc, 250 ng) and T7-expression
plasmid (pCAGGs-T7opt, 250 ng) were co-transfected with four ZEBOV expression
plasmids (pCAGGs-ZEBOV-NP, pCAGGs-ZEBOV-VP35, pCAGGs-ZEBOV-VP30,
pCAGGs-ZEBOV-Lpol; 250 ng each) or multicistronic constructs (ZEBOV-4cis, 1000 ng),
and pCAGGs empty vector for a total of 1500 ng DNA per 0.5E6 HEK293T cells using
calcium phosphate transfection (see method above). Suspension transfected cells were
seeded at a density of 20,000 cells/well into 8 wells of 96-well plates for 2 days in duplicates.
Nano luciferase assays for minigenome function and cell titer glo assays for cell viability
were performed as per manufacturer’s instructions (Promega). For minigenome assays in
ZEBOV-4cis stable cells, 500 ng each of p2.0-T7-3E5E-nLuc or p2.0-T7-3E5E-eGFP and
500ng of T7-expression plasmid were co-transfected. Nano luciferase levels were assayed as
above and eGFP signal was captured via microscopy (Leica, 4X magnification).
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3.10.3 Statistical analysis
Bar plots show mean of biological replicates and, when shown, error bars denote 95%
confidence intervals of mean. Statistical analysis was done in Python
(https://github.com/jpfon/MTK).
3.10.4 Data availability
All supporting data for the findings and plasmids presented in this study are available on
github (https://github.com/jpfon/MTK).
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3.13 Figures
Figure 3.1: Schematic and definition of parts of the Mammalian Toolkit (MTK).
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a. Workflow of the MTK starting with a BsmBI part domestication, BsaI
transcriptional unit assembly, and a final BsmBI assembly of a multi-transcriptional unit
plasmid. Top text indicates approximate time from initial PCR with primers to receiving
final plasmid. b. Schematic of a standard transcriptional unit (TU). Tables below part
definition summarize variations of that part that are present in the MTK. Supplemental
table 1 contains a comprehensive list of current parts. c. Library of TUs can be re-used
with no further modification and delivered to cells in three methods already present in the
MTK using a dedicated destination vector (MTK part 0).
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Figure 3.2: Characterization of constitutive promoters,3’ UTR and multicistronic connectors
provided in the MTK.
a. Top: Schematic of a TU used to quantify promoter expression. Bottom:
Ranked expression of mAzamiGreen (normalized to a constitutive mScarlet) driven by
different promoters. Distributions show one of four biological replicates, and bar plots
represent the mean of all four biological replicates. The mean of each replicate is also
shown as a black dot. The letter “c” following the name of a promoter (e.g PGK1 versus
PGK1c) is used to designate a “crippled” promoter where the Kozak sequence is disrupted.
b Top: Schematic of TU used to quantify the effect of the 3’ UTR on mAzamiGreen
expression driven by the EF1a promoter. Data representation is as described above. c
Schematic of expression strategies of 4 fluorescent proteins targeted to 4 different cellular
locations. In the first strategy, a plasmid contains 4 TUs, each containing a CAG
promoter. In the first TU, CAG drives expression of membrane-targeted iRFP713
(Lyn::iRFP713), in the second expression of cytoplasmic mAzamiGreen
(NES::mAzamiGreen), in the third expression of p38 kinase translocation reporter fused to
mCerulean (Cerulean::p38KTR), and in the fourth histone H2B fused to mScarlet
(H2B::mScarlet). In the second strategy, a multicistronic plasmid encodes the same
proteins, but all are produced from a single transcript driven by a CAG promoter with 3
P2A sequences separating the 4 peptides. The size in bp of each plasmid is also indicated.
dConfocal images of HEK293T cells expressing the 4 promoter (top) or multicistronic
(bottom) plasmid. Merge panel shows Lyn::iRFP713 in white, NES::mAzamiGreen in
green, Cerulean::p38KTR in blue and H2B::mScarlet in red.
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Figure 3.3: Generation and testing of landing pads for HEK293T cells using the MTK.
a. Schematic of landing pad, transfer vector and integrated vector. Also shown
are genotyping primers. FRT, flippase recognition target; ins., Insulator; LoxP; LoxP site;
attP, BxBI phage attachment site; hph, hygromycin resistance gene, bls, blasticidin
resistance gene; NLS, nuclear localization signal; KanR, kanamycin resistance gene; colE1,
colE1 origin of replication; attB, BxBI bacterial attachment site; mAzamiG,
mAzamiGreen. b mRuby2, mAzamiGreen and tagBFP expression in populations of
parental, Landing pad and Landing Pad with Transfer vector HEK293T cells. mRuby2
expression indicates presence of hAAVS1 landing pad. mAzamiGreen and tagBFP
expression indicates precise integration of transfer vector in hAAVS1 landing pad.
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Figure 3.4: Combinatorial assembly of complex libraries using the MTK.
a Overview of the MTK strategy for a combinatorial, one pot, generation of a
library containing 12 combinations of 4 different fluorescent proteins (FP) targeted to three
cellular locations. The final multi-TU construct is composed of 3 TUs: EF1a driving the
nuclear localization of an FP; CMV expressing the cytoplasmic localization of an FP; and
CAG producing a membrane-tethered FP. Each FP is one of 4 variable fluorophores
(tagBFP, mAzamiGreen, mScarlet and iRFP713), giving a total of 64 possible variants.
Constructs are delivered to the landing pad in HEK293T cells. b Confocal image of
HEK293T+LP, transfected with pooled library in panel (a). iRFP713 shown in white,
mScarlet shown in red, mAzamiGreen shown in green and tagBFP shown in blue. Merge
and close-up show cells expressing 3 FPs in three subcellular locations displaying the
variety of expected combinations. c Overview of the MTK strategy for a combinatorial,
one pot, library of lentiviral vectors carrying sgRNAs targeting tagBFP, mScarlet, both or
non-targeting. The final multi-TU construct is composed of three TUs: mU6 promoter
driving the expression of mScarlet or non-targeting sgRNA; mU6 promoter driving the
expression of tagBFP or non-targeting sgRNA; EF1a driving the expression of iRFP713 for
identification of cells that have integrated the construct. Library was produced and
transduced to HEK293T cells expressing tagBFP, mScarlet and Cas9 fused to
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mAzamiGreen (3C cells). d Scatter plots of tagBFP and mScarlet fluorescence in
populations of 3C cells where sgRNAs were individually expressed to target tagBFP,
mScarlet, tagBFP and mScarlet, or with non-targeting sgRNA. Last panel shows the
scatter plots of tagBFP and mScarlet fluorescence in populations transfected with
combinatorially assembled library of sgRNAs. e Scatter plot of tagBFP and mScarlet
fluorescence in populations of 3C cells, where an equal number of cells expresses sgRNAs
that target tagBFP, mScarlet, tagBFP and mScarlet, or with non-targeting sgRNA.
Shaded areas correspond to 4 classes identified by a linear classifier (green, non-targeting;
blue, tagBFP; orange, mScarlet; pink, mScarlet and tagBFP). f Expected fraction of cells
expressing different guide combinations as identified by linear classifier in panel (e) where 4
sgRNA combinations have equal ratios. g Measured fraction of cells expressing different
guide combinations in combinatorial assembly is similar to (f). Bar plot and error bars
represents mean and 95% CI of four biological repeats. NLS, Nuclear localization signal;
NES, nuclear export signal; Lyn, plasma membrane tag; mAzamiG, mAzamiGreen.
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Figure 3.5: Parallelization of dCas9 circuit prototyping using the MTK.
a Schematic of 12 dCas9 circuit variations assembled in parallel. Each variation is
a multi-TU plasmid with either a TRE or UAS inducible promoter controlling the
expression of mAzamiGreen, followed by EF1a driving either dSpCas9 or dSaCas9 fused to
a KRAB domain, fluorophore, or VPR domain. UAS, Upstream Activating Sequence.TRE,
Tetracycline Responsive Element. dSpCas9 and dSaCas9, deactivated S. pyogenes and S.
aureus Cas9, respectively. KRAB, Krueppel-associated box. FP, fluorescent protein. VPR,
VP64-p65-Rta. b mAzamiGreen expression (normalized by iRFP713) for different
configurations of the circuit. Every row is a different configuration, corresponding to a
variation of the promoter, dCas9 used, and effector used. Configurations are grouped by
their promoter-dCas9 pairing (different groups are separated by solid lines). Bar plot
represents mean of 4 biological replicates, the mean of each is shown as a black dot.
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Figure 3.6: Generating multicistronic constructs for Zaire ebolavirus ribonucleoproteins in a
mammalian cell host using the MTK.
a Schematic of the different constructs. Panel 1: Schematic of the Zaire ebolavirus
(ZEBOV) negative sense single stranded RNA (-ssRNA) genome. Panel 2: Functional
minigenome assay for ZEBOV using the 6 plasmid system that includes expression
constructs for NP, VP35, VP30, and Lpol viral proteins as well as the T7 polymerase along
with a T7-driven minigenome reporter construct flanked by viral non coding 3’ and 5’
UTRs, the leader and trailer, respectively. Transfection of the 6 plasmids into mammalian
cells results in expression of NP, VP35, VP30, Lpol, and T7 and transcription of the
minigenome viral RNA (vRNA(-)). The vRNA(-) is replicated to generate antigenomic
RNA (aRNA(+)) and transcribed into mRNA by the viral proteins to yield reporter gene
expression. Panel 3: Schematic of the Zaire ebolavirus multicistronic construct
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(ZEBOV-4cis) with NP, VP35, VP30, and Lpol separated by P2A ribosomal skipping site
elements. b Luminescence measurements of ZEBOV minigenome activity. HEK293T cells
were transfected with ZEBOV nano luciferase (nLuc) minigenome in combination with
pCAGGs empty control plasmid (control), the ZEBOV 6 plasmids (with or without Lpol:
+Lpol, -Lpol), or with ZEBOV-4cis in PiggyBac part 0 vector. Positive (+) and negative
(-) controls for nLuc expression levels include transfection of only pCAGGS-nLuc plasmid
or pCAGGs empty plasmid, respectively. Nano luciferase activity was measured two days
post transfection. Bar plots represent the mean of biological replicates (n=2). c Schematic
of ZEBOV-4cis stable cell line generation using PiggyBac transposon. HEK293T cells were
co-transfected with MTK043-ZEBOV-4cis and a PiggyBac expression construct for 3 days
and selected with hygromycin for 7 days to generate stable cell populations expressing
ZEBOV RNP complex proteins. Clones were isolated from these populations via limited
dilution plating in additional 10-20 days. d Luminescence measurements of minigenome
activity in ZEBOV-4cis stable population. ZEBOV-4cis stable cells and clones were
transfected with a T7-driven ZEBOV minigenome construct encoding an nLuc reporter
along with T7 polymerase for 2 days followed by nano luciferase assay. Bar plots represent
mean of technical replicates (n=10). e Western blot confirmation of protein expression.
ZEBOV-4cis stable population and clones as well as HEK293T cells transfected with
MTK0-43-ZEBOV-4cis were processed for Western blot analysis with mouse anti-ZEBOV
VP35, rabbit anti-ZEBOV-NP, mouse anti-2A peptide, and rabbit anti-GAPDH
antibodies. f Immunofluorescence analysis of viral protein localization. ZEBOV-4cis
population and clone were stained with with anti-2A peptide and anti-ZEBOV-VP35
primary antibodies and Alexa-488 secondary antibody. DAPI stained nuclei are shown in
the merged images. Insets represent 2X magnified fields. g Effect of chemical compound
inhibitors on minigenome activity in ZEBOV-4cis stable cells. ZEBOV-4cis stable
population was transfected with a ZEBOV minigenome construct encoding a nano
luciferase reporter and treated with DMSO (1%), Gedunin (5uM), or 6-Azauridine (5uM).
After 2 days cells were processed for nano luciferase assay for functional minigenome
activity and cell titer glo assays for cell viability. Levels of signal relative to DMSO control
is plotted. Bar plots represent mean of biological replicates (n=2).
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3.14 Supplemental Data Figures
Figure 3.7: Comparison of constitutive promoters across cell lines and delivery methods.
a The mAzamiGreen expression from transient transfection and PiggyBac
integration of each promoter was assessed in HEK293T and b NIH3T3 cells. c
mAzamiGreen expression of each promoter was compared between HEK293T and NIN3T3
in transient expression and d PiggyBac integration. Each point represents the mean of four
biological replicates and error bars represent the standard deviation across replicates.
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Figure 3.8: Comparison of impact of 3’ UTRs across cell lines and delivery methods.
a The mAzamiGreen expression from transient transfection and PiggyBac
integration delivery of each 3’ UTR was assessed in HEK293T and b NIH3T3 cells. c
mAzamiGreen expression of each 3’ UTR was compared between HEK293T and NIN3T3
in transient expression and d PiggyBac integration. Each point represents the mean of four
biological replicates and error bars represent the standard deviation across replicates.
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Figure 3.9: Generation of landing pads for human cell lines.
a PCR products from landing pad genotyping. P1+P3 indicate presence of WT
hAVVS1 locus and P2+P3 indicate presence of BxBI landing pad in hAAVS1 locus.
mRuby2, mAzamiGreen and tagBFP expression in populations of parental, Landing pad
and Landing Pad with Transfer vector HEK293T cells. b mRuby2, mAzamiGreen and
tagBFP expression in populations of parental, Landing pad 2 and Landing Pad 2 with
Transfer vector HEK293T cells. In this clone, both wild type alleles of hAAVS1 locus were
replaced by the landing pad construct, showing two populations as measured by
fluorescence upon integration of the transfer vector and suggesting these two populations
had one or two copies that integrated into the genome. mRuby2 expression indicates
presence of hAAVS1 landing pad. mAzamiGreen and tagBFP expression indicates precise
integration of transfer vector in hAAVS1 landing pad.
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Figure 3.10: Building a linear classifier to distinguish target sgRNA knockdown populations.
a Classification report of linear classifier. b. Confusion matrix of linear classifier.
75
Figure 3.11: Generation and quality control of multicistronic constructs for Zaire ebolavirus
ribonucleoproteins.
a Multicistronic construct cloning efficiency. ZEBOV multicistronic construct
containing 4 viral ORFs separated by P2A elements (ZEBOV-4cis) was BsmBI assembled
directly into donor vectors for genome engineering. Specifically, ZEBOV-4cis was generated
in donor vectors for PiggyBac transposon (MTK0-43), PhiC31 Integrase (MTK0-13,
MTK0-16 tagBFP), and BxBI Integrase (MTK0-14, MTK0-17 tagBFP). The number of
bacterial colonies screened and positive for correct construct by size (NotI digestions) is
indicated. b. Luminescence measurements of ZEBOV minigenome activity and cell
viability. HEK293T cells were transfected with ZEBOV nLuc minigenome in combination
with pCAGGs empty control plasmid (control), the ZEBOV 6 plasmids (with or without
Lpol: +Lpol, -Lpol), or with ZEBOV-4cis in various part 0 donor vectors. Positive (+) and
negative (-) controls include transfection of only pCAGGS-nLuc plasmid or pCAGGs
empty plasmid, respectively. Nano luciferase activity was measured two days post
transfection. Bar plots represent the mean of biological replicates (n=2).c GFP analysis of
minigenome activity in stable cells. ZEBOV-4cis stable populations and clones were
transfected with a T7-driven ZEBOV minigenome construct encoding the eGFP reporter
along with T7 polymerase. After 2 days cells were imaged for GFP detection (Leica, 4X).
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Table 3.5: Connector part overhangs
Connector Overhang
LS, LS’ 5’ CTGA
L1, R1 5’ CCAA
L2, R2 5’ GATG
L3, R3 5’ GTTC
L4, R4 5’ GGTA
L5, R5 5’ AAGT
L6, R6 5’ CCCT
L7, R7 5’ GCGG
L8, R8 5’ TTTA
RE, RE’ 5’ AGCA
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